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ABSTRACT 
 
Satellite cells are the major resident stem cell population in 
postnatal skeletal muscle and they are necessary to achieve a 
proper regeneration response. However in recent years other 
resident progenitor populations have been described. PW1/Peg3 is 
expressed in stem cells and progenitor populations in several 
murine postnatal tissues. In skeletal muscle PW1/Peg3 is expressed 
in satellite cells and a subset of interstitial cells (PICs, PW1+ 
Interstitial Cells).  Microarray analysis revealed that PICs express a 
broad range of genes common to mesenchymal stem cells while 
satellite cells express genes consistent with a committed myogenic 
progenitor. We found that juvenile and adult PICs are more plastic 
than satellite cells, as they are able to differentiate in vitro into 
smooth and skeletal muscle as well as fat, while satellite cells only 
exhibit a committed skeletal muscle fate. Moreover, we found that 
PICs can be separated into 2 sub-populations on the basis of 
platelet derived growth factor receptor alpha (PDGFRα) 
expression: PW1+PDGFRα+ with adipogenic capacity and 
PW1+PDGFRα- with myogenic capacity. 
Transforming growth factor beta (TGFβ) and insulin-like 
growth factor-1 (IGF-1) signalling pathways are involved in 
important processes regulating postnatal muscle growth and 
homeostasis and have recently become pharmaceutical and clinical 
targets in several chronic diseases in which muscle regeneration is 
impaired. We found that PICs can rescue myostatin inhibitory 
effects on satellite cells proliferation in vitro through release of 
antagonist factors, including follistatin and IGF-1, demonstrating 
cellular crosstalk within the muscle stem cell niche. Moreover, 
administering an inhibitor of the TGFβ pathway in vivo acts on the 
stem cell niche interactions by altering the ratio between PICs and 
satellite cells and it is able to rescue regenerative capacity in 
satellite cell-deprived muscles by creating a favourable 
microenvironment where rare residual satellite cells can be 
mobilized and participate to muscle fiber regeneration. 
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RIASSUNTO 
 
Le cellule satelliti costituiscono la principale popolazione di 
progenitori cellulari presenti nel muscolo scheletrico postnatale e 
contribuiscono alla rigenerazione muscolare (Relaix et al., 2012; 
Yin et al., 2013). Tuttavia, negli ultimi decenni sono stati descritti 
altri tipi di progenitori cellulari con capacità miogenica in vitro e in 
seguito a iniezione sistemica o intramuscolare, che contribuiscono 
alla rigenerazione muscolare in vivo (Cappellari and Cossu, 2013; 
Mitchell et al., 2010; Pannerec et al., 2012; Yin et al., 2013). Il 
possibile ruolo di questi progenitori nella crescita muscolare 
postnatale è al momento in corso di studio (Pannerec et al., 2012). 
Nel nostro laboratorio è stata in precedenza descritta nel muscolo 
postnatale una sottopopolazione di cellule  interstiziali esprimenti 
PW1/Peg3, definite PICs (PW1+ Interstitial Cells) e dotate di 
un’alta capacità miogenica in vitro e in seguito a trapianto in 
muscoli danneggiati (Mitchell et al., 2010). Inoltre, le PICs 
trapiantate in un muscolo danneggiato non soltanto partecipano 
alla rigenerazione delle fibre muscolari, ma possono anche 
generare satelliti ed altre PICs, esibendo quindi capacità di 
autorinnovamento (Mitchell et al., 2010). In vitro le PICs sono 
bipotenti, in quanto in grado di differenziare non solo in cellule 
muscolari scheletriche, ma anche in cellule muscolari lisce 
(Mitchell et al., 2010). Queste osservazioni suggeriscono che le 
PICs siano progenitori cellulari dotati di una maggiore plasticità 
rispetto alle cellule satelliti. Una tale ipotesi è inoltre sostenuta da 
un recente studio svolto nel nostro laboratorio sul modello murino 
reporter PW1IRESnLacZ, da cui è emerso che PW1/Peg3 è espresso 
nel topo adulto nelle differenti popolazioni di cellule staminali 
presenti in tutti i tessuti esaminati (muscolo scheletrico, intestino, 
sistema nervoso centrale, midollo osseo, gonadi, pelle) (Besson et 
al., 2011). E’ dunque plausibile che le cellule esprimenti PW1 nel 
muscolo scheletrico, tra cui satelliti e PICs, siano progenitori 
cellulari dotati di diverse capacità differenziative. Il primo scopo 
di questo lavoro è di descrivere le capacità di differenziamento 
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delle differenti popolazioni di progenitori cellulari del muscolo 
scheletrico nel periodo di crescita postnatale. A questo fine, 
abbiamo messo a punto una tecnica di isolamento tramite 
citometria a flusso (FACS, Fluorescence-Activated Cell Sorting) 
delle cellule satelliti e delle PICs dai muscoli scheletrici degli arti 
inferiori, attraverso una selezione negativa per i marcatori 
ematopoietici di membrana CD45 e Ter119, seguita da una 
selezione positiva per i marcatori di cellule staminali CD34 e Sca1, 
come precedentemente descritto (Sacco et al., 2008; Joe et al., 
2010; Mitchell et al., 2010). Nei topi giovani (1 settimana di vita 
postnatale), abbiamo distinto sulla base dei livelli di espressione di 
Sca1 due popolazioni di PICs (Sca1MED e Sca1HIGH): la 
popolazione Sca1MED è arricchita in PICs, mentre la Sca1HIGH è una 
popolazione mista in cui sono presenti cellule PW1-positive e 
PW1-negative (Mitchell et al., 2010). Per tale ragione, in 
precedenza abbiamo limitato la descrizione delle PICs alla 
popolazione Sca1MED (Mitchell et al., 2010). La disponibilità del 
modello murino transgenico “reporter” PW1IRESnLacZ (Besson et al., 
2011) ci ha permesso di isolare tramite FACS le cellule esprimenti 
PW1 nella popolazione Sca1HIGH e di analizzare sistematicamente 
le capacità di differenziamento in vitro delle PICs (sia Sca1MED che 
Sca1HIGH), a partire da 1 settimana di vita postnatale fino all’adulto 
(7 settimane). Abbiamo osservato che le PICs sono in grado di 
differenziare in cellule muscolari lisce, cellule muscolari 
scheletriche e adipociti, contrariamente alle cellule PW1-negative, 
le quali possono differenziare soltanto in cellule muscolari lisce. 
Recentemente, sono state descritte nel muscolo scheletrico adulto 
cellule interstiziali esprimenti Sca1 e PDGFRα  e dotate di 
capacità adipogenica (Joe et al., 2010; Uezumi et al., 2010; 
Uezumi et al., 2011), qui denominate IAPs (Interstitial Adipogenic 
Progenitors). In vivo le IAPs non partecipano direttamente alla 
rigenerazione delle fibre muscolari danneggiate, tuttavia sono 
rapidamente indotte a proliferare in seguito a danno (Joe et al., 
2010; Uezumi et al., 2010; Uezumi et al., 2011). In vitro le IAPs 
mostrano un effetto promiogenico nei confronti delle cellule 
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satelliti, mentre la presenza di cellule muscolari differenziate in 
coltura è in grado di inibire il differenziamento adipogenico delle 
IAPs (Joe et al., 2010; Uezumi et al., 2010). Ciò lascia supporre 
l'esistenza di un'interazione reciproca tra le IAPs e le cellule 
satelliti durante la rigenerazione muscolare e un ruolo importante 
delle IAPs nel regolare l'attivazione e il differenziamento delle 
cellule satelliti. Per determinare se le PICs e le IAPs fossero 
popolazioni correlate o distinte, abbiamo purificato le cellule in 
base alla loro espressione di PDGFRα e di PW1 ed analizzato le 
capacità di differenziamento in vitro delle popolazioni ottenute. In 
questo modo abbiamo dimostrato che le IAPs costituiscono una 
sottopopolazione delle PICs ad esclusiva capacità adipogenica e 
che le PICs comprendono anche un'altra sottopopolazione di 
cellule non esprimenti PDGFRα e dotate di capacità miogenica, 
ma non adipogenica. Dalle nostre analisi è inoltre emerso che la 
popolazione di PICs esprimenti livelli intermedi di Sca1 (Sca1MED) 
decresce progressivamente dopo la nascita fino a scomparire tra le 
3 e le 5 settimane di vita postnatale. Vari studi suggeriscono che il 
principale meccanismo di crescita postnatale fino alle 3 settimane 
consista nella fusione di progenitori cellulari alle fibre muscolari, 
mentre dopo questa fase la crescita muscolare avvenga 
generalmente per un'ipertrofia delle fibre (White et al., 2010). 
Questo cambiamento nel programma cellulare miogenico 
postnatale è anche sostenuto da un cambiamento di espressione 
genica (Lepper et al., 2009). In base ai risultati da noi ottenuti, 
possiamo supporre che questa popolazione transitoria di PICs 
(Sca1MED) sia coinvolta nella prima fase della miogenesi 
postnatale, sia direttamente attraverso la fusione alle fibre 
muscolari, sia indirettamente come elemento di supporto 
funzionale per altri progenitori cellulari, in primo luogo le cellule 
satelliti, attraverso la secrezione di molecole di segnalazione.   
Una più dettagliata comprensione della nicchia delle cellule 
staminali del muscolo scheletrico e delle sue componenti è 
importante in quanto può fornire una base teorica e sperimentale 
per progettare trattamenti terapeutici per le malattie muscolari. 
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Nelle malattie degenerative come le distrofie muscolari congenite, 
nell'atrofia muscolare presente in patologie croniche (cancro, 
diabete, insufficienza renale o cardiaca) o nell’invecchiamento, si 
assiste ad una perdita della massa e della forza contrattile dei 
muscoli scheletrici, fenomeni generalmente associati ad una cattiva 
prognosi e alla morte (Mann et al., 2011; Tabebordbar et al., 2013). 
Queste miopatie sono inoltre associate ad un aumento dell’attività 
catabolica muscolare e/o ad una degenerazione delle fibre 
muscolari, eventi che si verificano contemporaneamente ad una 
deposizione di tessuto fibrotico e adiposo, nonché ad una riduzione 
del numero delle cellule satelliti o ad un'alterazione della loro 
competenza (Mann et al., 2011; Bonaldo and Sandri, 2013; Hikida, 
2011; Jang et al., 2011). In queste condizioni patologiche 
l'attivazione della via di trasduzione del segnale che fa capo al 
recettore dell'activina di tipo 2B (AcvR2B, Activin Receptor type 
2B) è perturbata (Serrano et al., 2011; Tabebordbar et al., 2013). 
L'inibizione di questa via di comunicazione attraverso la 
somministrazione di molecole solubili o in modelli murini 
transgenici è in grado di ridurre la perdita di massa e forza 
muscolari in condizioni patologiche, diminuire la fibrosi e 
probabilmente attivare le cellule satelliti promuovendone la fusione 
alle fibre muscolari (George Carlson et al., 2011; Pistilli et al., 
2011; Morrison et al., 2009; Zhou et al., 2010a; Chiu et al., 2013; 
McCroskery et al., 2003; McCroskery et al., 2005). Gli studi 
effettuati sulle IAPs hanno mostrato che tali progenitori possono 
differenziare in adipociti in vivo soltanto in modelli in cui la 
rigenerazione muscolare è compromessa (Joe et al., 2010; Uezumi 
et al., 2011). Inoltre un'attivazione cronica della via di trasduzione 
dell’AcvR2B è uno dei principali stimoli responsabili del 
differenziamento adipogenico delle IAPs in vivo e della produzione 
e deposizione di matrice extracellulare fibrotica nel modello 
murino mdx per la distrofia muscolare di Duchenne (Uezumi et al., 
2011). Negli ultimi anni sono stati generati diversi modelli murini 
in cui il compartimento delle cellule satelliti può essere 
selettivamente ridotto, che offrono un eccellente paradigma per lo 
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studio delle patologie muscolari caratterizzate da una drastica 
diminuzione del numero di cellule satelliti (Lepper et al., 2011; 
Sambasivan et al., 2011b). Grazie a tali modelli è stato dimostrato 
che le cellule satelliti sono necessarie per garantire una corretta 
rigenerazione muscolare e che altri progenitori cellulari con 
capacità miogenica nota, come ad esempio le PICs, non possono 
compensare l’assenza delle cellule satelliti (Lepper et al., 2011; 
Sambasivan et al., 2011b). Queste osservazioni hanno condotto a 
formulare l’ipotesi di un "livello soglia" o quorum, ossia di un 
numero minimo di cellule satelliti necessarie per assicurare una 
corretta rigenerazione muscolare, numero al di sotto del quale il 
processo rigenerativo è compromesso e si assiste ad una 
deposizione di tessuto fibrotico e adiposo (Sambasivan et al., 
2011b). Il secondo scopo di questo lavoro è dunque chiarire il 
ruolo delle PICs nel muscolo adulto e le possibili interazioni 
con le cellule satelliti, durante fenomeni quali l'ipertrofia 
muscolare e la rigenerazione. Un’analisi del trascrittoma delle PICs 
e delle cellule satelliti isolate da topi giovani ha rivelato che gli 
effettori della via di trasduzione del segnale dell'AcvR2B sono 
diversamente espressi tra le PICs e le cellule satelliti, suggerendo 
l'esistenza di una comunicazione tra questi due tipi cellulari. 
Abbiamo dimostrato che in vitro le PICs esercitano un effetto 
promiogenico sulle cellule satelliti attraverso la secrezione di IGF-
1 e follistatina, molecole che agiscono antagonizzando la via del 
segnale dell’AcvR2B nelle cellule satelliti. Per meglio definire tale 
interazione in vivo, abbiamo utilizzato una forma solubile 
dell'AcvR2B (RAP-031, Acceleron Pharma, USA) che compete 
con l'AcvR2B endogeno per il legame alle relative molecole 
attivatrici. Abbiamo osservato che la somministrazione per via 
intraperitoneale di RAP-031 in topi adulti causa una notevole 
alterazione della nicchia delle cellule staminali attraverso un 
aumento del numero delle cellule satelliti e, in misura maggiore, 
delle PICs. La somministrazione di RAP-031 non recupera in 
modo significativo le poche cellule satelliti presenti in un modello 
murino di deplezione delle cellule satelliti (Pax7DTR/+) 
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(Sambasivan et al., 2011b), nonostante il significativo e notevole 
aumento delle PICs. Avendo dimostrato in precedenza in questo 
lavoro che le PICs adulte includono una sottopopolazione di cellule 
a capacità miogenica, abbiamo investigato la possibilità che tale 
popolazione cellulare potesse essere mobilitata in situ nel modello 
murino Pax7DTR/+ attraverso l'inibizione della via di trasduzione 
dell’AcvR2B. I risultati ottenuti hanno mostrato che, in muscoli 
privati delle cellule satelliti, il trattamento con RAP-031 è in grado 
di migliorare l'omeostasi tissutale in seguito a danno, attraverso 
una riduzione della deposizione di tessuto fibrotico e adiposo ed un 
significativo recupero della capacità rigenerativa. Tramite uno 
studio di “lineage tracing”, abbiamo inoltre dimostrato che 
l'aumento delle fibre rigeneranti in tali condizioni è dovuto a 
fusione delle cellule satelliti sopravvissute all’ablazione e non 
coinvolge altri progenitori cellulari, ad esempio le PICs, 
confermando risultati ottenuti da studi precedenti (Lepper et al., 
2011; Sambasivan et al., 2011b). Proponiamo, quindi, che il 
marcato aumento delle PICs causato dall’inibizione della via di 
trasduzione del segnale dell’AcvR2B sia in grado di creare un 
microambiente promiogenico, attraverso un aumentato rilascio di 
fattori quali IGF-1 e follistatina, capace di stimolare le cellule 
satelliti residue promuovendo la rigenerazione. I nostri studi di 
“lineage tracing” indicano che la maggioranza delle fibre 
rigenerate nel modello murino Pax7DTR/+ in seguito a inibizione 
della via di trasduzione dell’AcvR2B deriva dalle cellule satelliti 
residue, tuttavia non possiamo escludere che le PICs o altri 
progenitori muscolari partecipino alla rigenerazione muscolare 
quando il compartimento delle cellule satellite è intatto. Questa 
questione richiederà ulteriori studi e la creazione di nuovi modelli 
murini con marcatori specifici della genealogia delle PICs 
miogeniche. Questi risultati indicano che future strategie 
terapeutiche per il miglioramento del potenziale rigenerativo del 
muscolo scheletrico in patologie croniche dovranno includere 
terapie mirate alla nicchia delle cellule staminali. 
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Alcuni muscoli, tuttavia, come i muscoli extraoculari 
(EOMs, ExtraOcular Muscles), sono resistenti a diverse distrofie 
muscolari (Porter et al., 1995; Porter, 2002). Ciò suggerisce 
l’esistenza di meccanismi endogeni muscolo-specifici presenti 
nella nicchia delle cellule staminali capaci di regolare in maniera 
più efficiente i processi rigenerativi. Il terzo scopo di questo 
lavoro è di analizzare la nicchia delle cellule staminali dei 
muscoli extraoculari in topi wild-type e nel modello murino 
mdx. Abbiamo osservato che gli EOMs possiedono per tutto l’arco 
della vita postnatale un numero di PICs più elevato rispetto alle 
cellule satelliti, contrariamente ai muscoli scheletrici degli arti in 
cui le PICs e le cellule satelliti sono presenti ad un rapporto 
costante 1:1 durante la crescita postnatale e l’età adulta. Abbiamo 
osservato che questo rapporto è alterato nei muscoli degli arti 
provenienti da topi anziani (18 mesi), con una forte diminuzione 
del numero delle PICs. Il rapporto tra questi due tipi cellulari è 
conservato negli EOMs, nonostante il declino nel numero di PICs e 
cellule satelliti con l’età negli EOMs come nei muscoli degli arti. 
L’analisi della nicchia delle cellule staminali degli EOMs di topi 
mdx non ha mostrato particolari differenze rispetto ad animali 
wild-type, a conferma dell’osservazione che gli EOMs di topi mdx 
non presentano segni patologici tipici della distrofia muscolare di 
Duchenne. E’ tuttavia interessante notare che il processo 
rigenerativo tipicamente osservato nei muscoli degli arti dei topi 
mdx induce un aumento del numero delle PICs e delle cellule 
satelliti a livelli paragonabili a quelli osservati negli EOMs di 
animali wild-type. Ciò lascia supporre che meccanismi 
normalmente presenti durante la rigenerazione muscolare capaci di 
promuovere eventi come la sopravvivenza cellulare, l’attivazione e 
il differenziamento dei progenitori cellulari, siano intrinseci alla 
nicchia delle cellule staminali degli EOMs. Ulteriori analisi di 
questo particolare tipo di muscoli scheletrici potranno svelare 
elementi utili per progettare trattamenti terapeutici per vari tipi di 
miopatie congenite, così come per l’atrofia muscolare. 
Luigi Formicola 
Pag 14  
INTRODUCTION 
 
1. The postnatal skeletal muscle stem cell niche 
 
Skeletal muscle is composed of post-mitotic multinucleated 
myofibers that constitute the minimal functional unit responsible 
for voluntary muscular contraction (Yin et al., 2013). In 1961, 
Alexander Mauro described a subset of cells in postnatal skeletal 
muscle that he called “satellite cells” because of their localization 
underneath the basal lamina but outside the myofiber plasma 
membrane (Mauro, 1961). Since this discovery, a significant effort 
by many laboratories has confirmed that satellite cells are the 
major muscle progenitor cell in postnatal skeletal muscle 
underlying both muscle regeneration and postnatal growth (Relaix 
and Zammit, 2012; Yablonka-Reuveni, 2011). In the past decade, 
other resident cell progenitor populations have been discovered, 
indicating that the muscle stem cell niche is more complex than 
previously thought and that multiple cell types are important 
regulators of muscle growth and regeneration (Pannerec et al., 
2012). As such, these cells provide novel therapeutic targets for 
genetic diseases or chronic disorders in which the muscle stem cell 
niche is compromised (Pannerec et al., 2012). 
 
1.1. Satellite cells 
  
1.1.1. Origin and role of satellite cells during muscle growth  
  
Adult satellite cells express the Pax7 gene, both in a 
quiescent and activated state (Sambasivan and Tajbakhsh, 2007). 
Satellite cells express other specific markers, such as M-cadherin 
(Irintchev et al., 1994) and α7-integrin (Burkin and Kaufman, 
1999; Yin et al., 2013), and can be detected by using the SM/C-2.6 
antibody (Fukada et al., 2004). Trunk and limb muscles, as well as 
their satellite cell compartment, derive from Pax3+ muscle 
progenitor cells (MPCs) migrating from the hypaxial domain of the 
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somites during embryonic development (Gros et al., 2005; Relaix 
et al., 2005; Schienda et al., 2006). These MPCs express Pax7 and 
undergo myogenic differentiation coupled with progenitor cell 
expansion (Kanisicak et al., 2009). The myogenic program 
includes a specific sequence of gene expression involving initial 
activation of Myf5 and MyoD, which in turn activate the expression 
of terminal differentiation genes including myogenin leading to 
cell cycle exit (Bismuth and Relaix, 2010; Sassoon et al., 1989; 
Shih et al., 2008). Myogenin promotes expression of genes coding 
for structural and contractile proteins of the myofibers, such as the 
myosin heavy chain (MHC) (Wright et al., 1989). Myoblasts which 
have exited the cell cycle then fuse with each other to generate 
multinucleated myofibers (Bismuth and Relaix, 2010). Some 
undifferentiated proliferating MPCs become enveloped by the 
basal lamina surrounding the emerging fibres and constitute the 
future pool of satellite cells in postnatal life (Bismuth and Relaix, 
2010; Yin et al., 2013). A switch in the myogenesis program 
occurs at birth and a part of the proliferating satellite cells starts 
entering quiescence, while the remaining satellite cells complete 
fusion to the existing myofibers to support postnatal muscle 
growth until 3 weeks of postnatal life in mice (Bismuth and Relaix, 
2010). At birth, Pax7-/- mice have normal muscles and are 
morphologically indistinguishable from their wild-type littermates, 
indicating that Pax7 expression is not required during embryonic 
development (Relaix et al., 2006; Seale et al., 2000). However, 
Pax7 expression is necessary after birth to promote satellite cell 
survival (Relaix et al., 2006). Pax7-/- mice fail to grow properly and 
are incapable of muscle regeneration and typically die around 14 
days after birth (Seale et al., 2000). Recent studies using inducible 
Pax7 knock-out mouse models confirm a strict requirement for 
Pax7 after birth until 3 weeks of postnatal life indicating the 
different genetic requirements for satellite cells during 
embryogenesis, postnatal growth and adult stages (Lepper et al., 
2009; Lepper et al., 2011; Sambasivan et al., 2011b).  
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Unlike trunk and limb MPCs, head muscles are derived from 
the most anterior portion of the mesoderm, called cranial 
mesoderm, which does not undergo segmentation into somites 
during embryonic development (Sambasivan et al., 2011a). The 
early genetic programs underlying head muscle formation are 
different in limb and trunk muscles, however (Harel et al., 2009; 
Shih et al., 2008). All head muscles except for the extraocular 
muscles (EOMs) derive from the paraxial portion of the cranial 
mesoderm and require Tbx1 as initiator of the MPC commitment 
program (Kelly et al., 2004; Sambasivan et al., 2009). The subset 
of EOMs originates from the prechordal cranial mesoderm (PCM), 
which is located anterior to the notochord and develops separately 
from the rest of the cranial mesoderm to later dislocate caudally 
and fuse with it (Evans and Noden, 2006; Noden and Francis-
West, 2006; Noden and Schneider, 2006; Sambasivan et al., 
2011a). MPCs from the EOMs strictly require Pitx2 for their 
survival and for subsequent expression of EOM fiber specific 
genes (Kitamura et al., 1999; Zacharias et al., 2011; Zhou et al., 
2011). In contrast, the genetic program driving commitment of 
head MPCs, including those originating the EOMs involve genes 
common to trunk and limb MPCs (i.e. Myf5, MyoD and myogenin) 
(Sambasivan et al., 2009; Sambasivan et al., 2011a).  
 
1.1.2. Role of satellite cells during regeneration 
  
Satellite cells enter the G0 cell cycle phase after completing 
postnatal muscle growth (Bismuth and Relaix, 2010; Buckingham 
and Montarras, 2008). This quiescent state is characterized by the 
expression of Pax7 in the absence of downstream markers such as 
MyoD or myogenin (Relaix and Zammit, 2012; Yin et al., 2013). 
Several soluble cytokines and molecules released by the 
surrounding cells (myofibers, microvasculature, interstitial cells, 
neuromuscular junctions and circulating or resident immune cells) 
as well as systemic factors maintain this quiescent state in satellite 
cells (Ten Broek et al., 2010). Moreover, the physical interactions 
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with the sarcolemma and the basal lamina also regulate satellite 
cell quiescence (Ten Broek et al., 2010; Yin et al., 2013). Freshly 
isolated satellite cells will spontaneously re-enter the cell cycle and 
activate the myogenic differentiation program (Musaro and 
Barberi, 2010), however contact with the myofiber is not sufficient 
to drive quiescence suggesting that other factors coming from the 
environment are needed (Beauchamp et al., 2000; Keire et al., 
2013). Satellite cells are able to re-enter the cell cycle in response 
to an acute injury or prolonged exercise and will execute that 
myogenic program through the expression of Myf5 and MyoD to 
generate a myoblast pool which then becomes committed to fuse to 
damaged fibres and generate new fibres (Yin et al., 2013; Zammit 
et al., 2006a; Zammit et al., 2006b). Some activated MyoD+ 
satellite cells then turn off MyoD expression and return to a 
quiescent state, conferring to satellite cells the status of real stem 
cells, as they are also able to self-renew and refill their pool (Yin et 
al., 2013; Zammit, 2008; Zammit et al., 2006a).  
 
1.2. Non-satellite cell progenitor populations 
 
In addition to satellite cells, other progenitor populations in 
postnatal skeletal muscle have been described, including pericytes, 
side population cells, β4-integrin+ interstitial cells, interstitial 
adipogenic progenitors and PICs (Pannerec et al., 2012; Yin et al., 
2013).  
 
1.2.1. Pericytes 
 
Pericytes are vessel-associated cells and are considered to be 
the adult counterpart of the embryonic mesoangioblasts (MABs) 
(Dellavalle et al., 2011; Dellavalle et al., 2007; Tonlorenzi et al., 
2007). Although MABs can be isolated from embryonic dorsal 
aorta and express endothelial markers, such as CD31, pericytes are 
found around small vessels of postnatal skeletal muscles and heart 
and do not express endothelial markers but they can be identified 
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through other specific markers such as alkaline phosphatase (ALP), 
neuronal-glial antigen 2 chondroitin sulfate proteoglycan (NG2), 
cluster of differentiation-146 (CD146) and platelet-derived growth 
factor receptor beta (PDGFRβ) (De Angelis et al., 1999; Dellavalle 
et al., 2007; Tonlorenzi et al., 2007). Nonetheless, similar to the 
situation with MABs, pericytes can be isolated from different 
species (mouse, dog, human), proliferate in culture and undergo 
differentiation into several mesodermal lineages including 
osteoblasts, chondroblasts, adipocytes, smooth muscle cells and 
myoblasts following appropriate stimulation in vitro (Barbuti et al., 
2010; De Angelis et al., 1999; Dellavalle et al., 2007; Doherty et 
al., 1998; Farrington-Rock et al., 2004; Tonlorenzi et al., 2007). In 
addition, pericytes injected into the systemic blood circulation of 
dystrophic mice are able to invade skeletal muscles and replace 
degenerated fibres as well as colonize the satellite cell niche 
(Dellavalle et al., 2011; Sampaolesi et al., 2006). Pericytes also 
play a role during normal unperturbed perinatal muscle growth by 
contributing to the growth of a minor amount of myofibers and by 
replenishing the satellite cell pool (Dellavalle et al., 2011). 
However, this contribution is minimal in adulthood and does not 
increase after injury, demonstrating that local resident pericytes do 
not directly participate in myofiber repair in the adult (Dellavalle et 
al., 2011). Pericytes constitute an heterogeneous population with 
regard to cell fate: two subpopulations of NG2+ pericytes have 
been recently described, one with myogenic capacity (PDGFRα-
Nestin-) and one with adipogenic capacity (PDGFRα+Nestin+) 
(Birbrair et al., 2013). Moreover, pericytes isolated from adult 
human brain can be reprogrammed in vitro to differentiate into 
neurons after retroviral-transduction with the neuronal 
differentiation regulators Sex Determining Region Y-Box 2 (Sox2) 
and mammalian achaete scute homolog-1 (Mash1) demonstrating a 
high plasticity in these cells (Karow et al., 2012). 
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1.2.2. β4-integrin+ cells  
 
It has been shown recently that β4-integrin is expressed in a 
population of cells located in the interstitium (Liadaki et al., 2012). 
A subset of the β4-integrin+ cells coexpress the endothelial marker 
CD31, however no β4-integrin+ cell expresses NG2 or Pax7, 
indicating that these cells are distinct from pericytes and satellite 
cells (Liadaki et al., 2012). The β4-integrin+ cells are highly 
myogenic, as they are able to differentiate into myotubes in vitro 
and repair damaged myofibers following engraftment in vivo, 
whereas the β4-integrin- cells do not share this behaviour (Liadaki 
et al., 2012). This study raises the possibility of an overlap of these 
described β4-integrin+ cells with a subpopulation of endothelial 
cells with myogenic capacity that has been described in human 
(Okada et al., 2008; Zheng et al., 2007) and possibly in mouse 
(Tamaki et al., 2002). Human myogenic endothelial cells also 
exhibit chondrogenic and osteogenic capacity (Zheng et al., 2013), 
however these cell fates were not tested for the β4-integrin+ cells 
(Liadaki et al., 2012). 
 
1.2.3. Side population cells 
 
Side population (SP) cells have been isolated from several 
tissues, notably hematopoietic stem cells (HSCs), based upon their 
capacity to exclude Hoesch33342 dye via the ATP-binding cassette 
sub-family G-member 2 transporter (Abcg2). SP cells exhibit a 
pronounced capacity to repopulate the stem cell niche (Bunting, 
2002; Zhou et al., 2001). In skeletal muscle, SP cells can be found 
in the interstitium and express Sca1 and CD45, but no known 
markers for satellite cells but nonetheless can differentiate into 
myotubes in vitro or in myoblasts co-cultures (Asakura et al., 
2002; Doyle et al., 2011; Meeson et al., 2004). Muscle SP cells can 
also efficiently participate in myofiber repair and satellite cell pool 
replenishment following engraftment (Doyle et al., 2011; Meeson 
et al., 2004). However, even though Abcg2+ cells markedly 
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increase after injury, they do not directly contribute to myofiber 
repair in situ and Abcg2-/- mice display an impaired regenerative 
response primarily due to disruption of proper macrophage 
recruitment (Doyle et al., 2011). Interestingly, a small subset of 
satellite cells are Abcg2+Sca1+ cells, in contrast to the Abcg2-Sca1- 
majority of satellite cells, and efficiently engraft in injured muscles 
(Tanaka et al., 2009). 
 
1.2.4. Interstitial adipogenic progenitors 
 
In 2010, two independent reports described the isolation of a 
skeletal muscle resident cell population with adipogenic potential. 
In one study, these cells were described as CD45-CD31-
CD34+Sca1+ cells, also called fibroadipogenic progenitors (FAPs) 
(Joe et al., 2010) whereas the second group described the isolation 
of CD45-CD31-SM/C-2.6-Sca1+PDGFRα+ cells, which are able to 
differentiate into fibroblasts, adipocytes and osteoblasts in culture 
(Uezumi et al., 2010). FAPs also express PDGFRα (Joe et al., 
2010). Further analyses showed the existence of a common 
Sca1+PDGFRα+ progenitor cell type responsible for adipose tissue 
and fibrosis deposition, thus confirming that these two populations 
constituted the same cell type (Uezumi et al., 2011). These 
progenitor cells, here referred to as interstitial adipogenic 
progenitors (IAPs), do not express Pax7, α7-integrin or other 
satellite cells markers and do not share a common developmental 
origin with satellite cells (Joe et al., 2010; Uezumi et al., 2010)). 
IAPs are not able to directly participate to myofiber repair nor to 
undergo adipocyte differentiation in vivo although they are 
activated following injury (Joe et al., 2010; Uezumi et al., 2010). 
In experimental models promoting compromised muscle 
regeneration and fibrosis, these progenitors differentiate in 
adipocytes and lead to fat and fibrotic tissue deposition following 
engraftment (Joe et al., 2010; Uezumi et al., 2010). Importantly, 
FAPs were described to promote differentiation of satellite cells in 
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vitro, suggesting important interactions between these two 
populations within the muscle stem cell niche (Joe et al., 2010). 
 
1.2.5. PICs 
 
Our laboratory described that PW1/Peg3 gene identifies both 
the satellite cells and a subset of interstitial cells which do not 
express satellite cell markers, nor CD31 nor smooth muscle actin 
(Sma) in juvenile muscle (Mitchell et al., 2010). These PW1+ 
Interstitial Cells termed PICs, were isolated from limb muscles 
after a negative selection for erythrocyte and haematopoietic stem 
cell markers Ter119 and CD45 and a positive selection for CD34 
and Sca1 (Mitchell et al., 2010). The Sca1+ cells can be subdivided 
into two subpopulations based on the level of Sca1 expression: 
Sca1MEDIUM and Sca1HIGH (Mitchell et al., 2010). PICs are present 
at high purity in the Sca1MEDIUM population (>80%), whereas they 
only accounted for about 50% of Sca1MEDIUM  population (Mitchell 
et al., 2010). Due to the absence of specific markers for FACS 
isolation of PICs, all the in vitro and in vivo analyses were 
performed initially using the Sca1MEDIUM PICs (Mitchell et al., 
2010). In culture, PICs display a bipotent cell fate capacity as they 
can spontaneously generate smooth muscle cells and myotubes 
(Mitchell et al., 2010). We demonstrated that PICs were not 
derived from Pax3+ progenitors during development, indicating 
that they do not share the same origin with satellite cells (Mitchell 
et al., 2010). Moreover, after engraftment in vivo into injured 
muscles, they are able to repair the damaged myofibers as well as 
replenish both the satellite cell and their own niche (Mitchell et al., 
2010). PIC number declined after birth, however in homeostatic 
muscles PICs remain in a 1:1 ratio with satellite cells (Mitchell et 
al., 2010). Nonetheless, PICs increased following muscle injury 
and interestingly in Pax7-/- mice, where they are present at even 
increased numbers (Mitchell et al., 2010), suggesting that the 
deregulation of a cell component may have dramatic consequences 
on the entire stem cell niche.  
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The role of PW1/Peg3 in progenitor cells in skeletal muscle 
has not been fully elucidated. Previous studies from our group 
showed that PW1 is expressed in vivo during early embryonic 
mesoderm and then downregulated as tissues differentiate (Relaix 
et al., 1996). A similar downregulation of PW1 is seen in primary 
myoblasts as well as myogenic cell line C2C12 in vitro (Coletti et 
al., 2002; Nicolas et al., 2005; Relaix et al., 1996; Schwarzkopf et 
al., 2006).  
Our group recently generated a Pw1IRESnLacZ transgenic 
reporter mouse model where a nuclear operon lactose gene 
(nLacZ) was inserted into the exon 9 of the PW1 gene locus using 
bacterial artificial chromosome (BAC) recombination technology 
(Besson et al., 2011). Through this model, PW1 was found to be 
expressed in stem/progenitor populations of all tissues examined in 
the adult, including skeletal muscle, intestine, testis, central 
nervous system, bone marrow and skin (Besson et al., 2011). In 
particular, the PW1 expression is tightly associated with stem cell 
competence and self-renewal capacity (Besson et al., 2011). 
Previous studies reported that PW1 participates in the tumor 
necrosis factor-alpha (TNFα) inflammatory pathway as well as the 
p53-mediated cell stress response leading to growth arrest and 
regulation of the myogenic differentiation (Coletti et al., 2002; 
Nicolas et al., 2005; Relaix et al., 2000; Relaix et al., 1998; 
Schwarzkopf et al., 2006). Taken together, these data suggest a 
role for PW1 in mediating cell stress responses in adult stem cells 
as well as cell fate outcomes. 
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2. Interactions within the muscle stem cell niche 
 
Satellite cells have long been considered to be the only muscle 
progenitor underlying postnatal muscle growth and regeneration 
(Relaix and Zammit, 2012; Wang and Rudnicki, 2012; Yin et al., 
2013). The discovery of multiple resident as well as non-resident 
progenitor populations with or without myogenic capacity raised 
fundamental issues concerning the direct or indirect contribution 
that these “alternative” populations to muscle growth and 
regeneration as well as the importance of satellite cells in 
orchestrating these processes (Pannerec et al., 2012). These 
findings also raised the question as to whether it would be possible 
to improve muscle regeneration by stimulating or engrafting non-
satellite cell progenitors in pathological settings where the satellite 
cell pool is reduced or has lost regenerative capacity as found in 
congenital muscular dystrophies, muscle atrophy or other muscle 
degenerative disorders (Johns et al., 2013; Mann et al., 2011; 
Sakuma and Yamaguchi, 2013; Serrano et al., 2011). The emerging 
idea from these studies is that the skeletal muscle stem cell niche is 
a complex environment in which cell-cell interactions are finely 
regulated to assure normal growth and regeneration and that the 
deregulation of any component compromises tissue homeostasis 
and repair. 
 
2.1. Regulation of muscle regeneration 
 
Adult skeletal muscle is a stable tissue with negligible cellular 
turn-over, but able to efficiently regenerate in response to tissue 
damage (Yin et al., 2013). Muscle regeneration is a complex 
phenomenon involving satellite cells as well as other local cell 
populations and a precise sequence of molecular and cellular 
events (Tabebordbar et al., 2013) (Fig. 1).  
After damage, necrotic myofibers release chemotactic factors 
for circulating neutrophils, which are recruited 1-6 hours after 
injury (Tabebordbar et al., 2013; Ten Broek et al., 2010; Yin et al., 
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2013). Proinflammatory macrophages, called M1, then invade the 
damaged site, reaching a peak at 24 hours after damage, and 
secrete TNFα, interleukin-1 (IL-1) and other inflammatory 
cytokines able to promote phagocytosis of cellular debris 
(Tabebordbar et al., 2013; Ten Broek et al., 2010; Yin et al., 2013). 
2-4 days after injury, anti-inflammatory macrophages, called M2, 
massively colonize the damaged tissue, where they reside until the 
end of regeneration, and secrete anti-inflammatory cytokines such 
as IL-10 as well as promyogenic factors, such as IGF-1 and 
hepatocyte growth factor (HGF), which promote satellite cell 
activation and proliferation (Tabebordbar et al., 2013; Ten Broek et 
al., 2010; Yin et al., 2013). Satellite cells in turn secrete attractive 
and stimulating factors for immune cells (Chazaud et al., 2003). 
Active immune cells also secrete a variety of matrix 
metalloproteinases, which contribute to the release of growth 
factors bounded to the molecules of the extracellular matrix and 
also properly direct the remodelling of muscle tissue structure 
(Carmeli et al., 2004; Yin et al., 2013). Several members of the 
fibroblast growth factor (FGF) family are also involved in muscle 
regeneration, although their exact role has still to be fully 
elucidated (Ten Broek et al., 2010; Yin et al., 2013). Inflammatory 
cells are fundamental, especially in the early phases after damage, 
as regeneration fails if recruitment of these cells is prevented 
(Lescaudron et al., 1999). 
IAPs and other populations of interstitial cells are additional 
key regulators of the regenerative process (Joe et al., 2010; 
Murphy et al., 2011; Uezumi et al., 2010). After injury, quiescent 
IAPs initiate a rapid and massive proliferation and accumulate in 
the damaged site (Joe et al., 2010; Uezumi et al., 2010; Uezumi et 
al., 2011). In co-culture experiments, IAPs favor satellite cell 
differentiation and their differentiation into adipocytes is inhibited 
in presence of myofibers, suggesting an important role during in 
vivo regeneration (Joe et al., 2010; Rodeheffer, 2010; Uezumi et 
al., 2010). Moreover, genetic depletion of Tcf4+ fibroblasts results 
in a precocious differentiation of satellite cells after injury, 
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depletion of the satellite cell pool and impaired myofiber formation 
(Murphy et al., 2011), indicating that other interstitial cell 
subpopulations regulate muscle regeneration. The vasculature is 
another important player during muscle regeneration: vascular 
endothelial growth factor (VEGF) and platelet-derived growth 
factor (PDGF) secreted by endothelial cells stimulate local 
angiogenesis, thus providing oxygen and nutrients (Yin et al., 
2013). Differentiating satellite cells and active immune cells are 
able to release these factors and satellite cells in turn secrete factors 
stimulating endothelial cells (Ten Broek et al., 2010).  
At the end of the regeneration process, signals coming from 
activated satellite cells, myofibers and immune cells, as TGFβ1 
and myostatin (MST), inhibit further activation of the myogenic 
program so that the repaired muscle can re-enter an homeostatic 
resting condition (Ten Broek et al., 2010).   
 
 
 
 
 
Figure 1. The muscle regeneration process. In normal homeostatic muscle (a), 
satellite cells (green) as well as IAPs (purple) are in a quiescent state. After an 
acute injury (thunder), circulating macrophages are attracted to the damaged site 
and start an inflammation response that culminates with the activation of 
satellite cells (b). Activated satellite cells repair the damaged myofibers, and this 
process is sustained by IAPs as well as anti-inflammatory macrophages (c). 
Once muscle fibres are completely repaired, both satellite cells and IAPs return 
to a quiescent state. Adapted from Tabebordbar et al., 2013.  
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2.2. Deregulation of muscle regeneration  
 
Several murine models have been generated in which satellite 
cells are specifically ablated providing compelling evidence that 
satellite cells are strictly required for proper muscle regeneration 
(Lepper et al., 2011; Murphy et al., 2011; Relaix and Zammit, 
2012; Sambasivan et al., 2011b). The satellite cell population is not 
completely eliminated in these satellite cell depletion models such 
that 5-10% of the population is spared (Sambasivan et al., 2011b) 
suggesting that a minimal number or quorum of satellite cells is 
required for proper regeneration (Sambasivan et al., 2011b). While 
proper regeneration does not occur when satellite cells are reduced 
in number, there is a significant accumulation of ectopic fat and 
fibrotic tissue (Lepper et al., 2011; Sambasivan et al., 2011b). 
Although these models demonstrate a key role for satellite cells, it 
has also been shown that muscle regeneration is severely 
compromised in the absence of interstitial cells consistent with the 
hypothesis that non-satellite cell progenitors play an important role 
for proper satellite cell function (Murphy et al., 2011). These 
results have particular bearing on a number of clinical settings 
including physiological age-related sarcopenia, cachexia (muscle 
atrophy) and muscular dystrophies in which patients show severely 
compromised regenerative capacity coupled with fat and fibrotic 
accumulation and a markedly reduced number of satellite cells 
(Sakuma and Yamaguchi, 2013; Serrano et al., 2011). It is 
therefore important to understand why the remaining satellite cells 
cannot compensate and expand further to properly execute the 
regenerative program. It has been shown that a small number of 
satellite cells (< 20) can generate thousands of muscle fibres and 
repopulate the satellite cell compartment when engrafted into 
healthy muscle tissue (Sacco et al., 2008). These data lead to the 
model that prolonged muscle disease alters the stem cell 
environment that further compromise the competence and potential 
of few remaining satellite cells.  
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Consistent with this notion, members of the TGFβ pathway 
have been shown to promote fibrosis in muscle tissue (Bernasconi 
et al., 1999; Serrano et al., 2011). These include TGFβ1, 
TGFβ2, TGFβ3 as well as PDGF, which are upregulated in 
muscles displaying a high level of fibrosis, as the diaphragm in 
mdx mice, a murine model for Duchenne muscular dystrophy 
(DMD) (Bernasconi et al., 1995; Partridge, 2013; Zhao et al., 2003; 
Zhou et al., 2006). In addition, transgenic mice displaying a 
constitutively active PDGFRα exhibit systemic fibrosis, including 
in the skeletal muscles (Olson and Soriano, 2009). These 
molecules are able to target IAPs by inducing proliferation and 
expression of ECM-related genes associated to fibrosis (Uezumi et 
al., 2011), indicating that IAPs are an important source of fibrosis 
when muscle regeneration signals are altered. Interestingly, IAPs 
are able to differentiate into adipocytes in vivo only in models 
where regeneration is defective, such as glycerol-injected muscles, 
indicating that an altered microenvironment can have profound 
effects on these cells (Joe et al., 2010; Uezumi et al., 2010). 
Furthermore, several reports showed that satellite cells exhibit a 
fibrogenic fate switch as well as lower regenerative capacity and 
increased apoptosis in aged mice but can be restored to normal 
adult function when exposed to circulating factors of young mice 
(Brack et al., 2007; Conboy et al., 2005; Day et al., 2010; Smythe 
et al., 2008). These data confirm the importance of the 
environment in regulating satellite cell biology and also that an 
altered niche, as the niche in aged or chronically ill individuals, 
account for satellite cell altered capacities.  
 
2.3. TGFβ  and IGF-1 pathways 
 
TGFβ and IGF-1 pathways are key regulators of muscle 
homeostasis and the balance of these signals is altered in 
sarcopenia, muscle atrophy and chronic diseases (Glass, 2010).  
One of the most studied TGFβ signaling pathway in skeletal 
muscle is triggered by the binding of specific extracellular ligands 
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to the activin transmembrane receptor (AcvR) type-2B (AcvR2B), 
which in turn binds to type-1 co-receptors Alk-4 or Alk-5 leading 
to the phosphorylation of intracellular Smad proteins and their 
subsequent translocation to the nucleus where they control gene 
expression and cell cycle arrest (Joulia et al., 2003; Rebbapragada 
et al., 2003; Zhu et al., 2004). Ligands for the AcvR2B include 
MST, growth/differentiation factor 11 (GDF-11/BMP-11) and 
activin A, while antagonists of this pathway are follistatin (FST), 
follistatin-like 3 (FSTL-3), GASP-1/GASP-2 and the myostatin 
propeptide (Amthor et al., 2004; Hill et al., 2002; Lee et al., 2010; 
Lee and McPherron, 2001; McPherron et al., 2009; Thies et al., 
2001). These molecules act through different combinations of type-
2 and type-1 receptors and show promiscuity for receptor binding, 
with a preference for the co-receptor type-1 depending on the cell 
type (Kemaladewi et al., 2012; Rebbapragada et al., 2003). For 
instance, MST can bind at high affinity to AcvR2B and at lower 
affinity to AcvR2A and has a preference for Alk-4 in myoblasts 
and for Alk-5 in nonmyogenic cells (Kemaladewi et al., 2012). 
MST is a major ligand for AcvR2B and a potent negative regulator 
of muscle growth, which blocks myogenic progression (Joulia et 
al., 2003; Lee and McPherron, 2001; McPherron et al., 1997; Rios 
et al., 2002; Thomas et al., 2000). Mst-null (Mst-/-) mice display a 
massive increase in muscle mass concomitant with a decrease in 
fat accumulation coupled with improved muscle regeneration and 
reduced fibrosis following injury (McCroskery et al., 2005; 
McPherron et al., 1997; McPherron and Lee, 2002). Natural 
occurring mutations in Mst have been described in cattle (Grobet et 
al., 1997; Kambadur et al., 1997; Oldham et al., 2001), dog 
(Mosher et al., 2007; Shelton and Engvall, 2007), sheep (Clop et 
al., 2006) and human (Schuelke et al., 2004), all displaying an 
increase in muscle mass similar to Mst-/- mice.  
Igf-1 is a multi-exon gene which undergoes alternative 
splicing to generate different isoforms that act either locally (non-
diffusible) or diffusibly as a function of tissue type and age 
(Oberbauer, 2013). Transcripts containing exon 1 are referred to as 
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“class 1”, while those containing exon 2 are referred to as “class 2” 
(Oberbauer, 2013; Philippou et al., 2007). IGF-1 isoforms also 
differ on the basis of their carboxy-terminus: in mouse, subclass 
named Ea includes exon 6 but not exon 5, while subclass Eb 
includes exon 5 and only a portion of exon 6 (Oberbauer, 2013; 
Philippou et al., 2007; Shavlakadze et al., 2005), although this 
splicing pattern is different for human IGF-1 (Adamo et al., 1993). 
The biological significance of these isoforms is still unclear, 
however class 1 transcripts have been proposed to act in an 
autocrine/paracrine way, while class 2 transcripts to be the 
circulating isoform (Gilmour, 1994; Oberbauer, 2013; Sussenbach 
et al., 1992). The Igf-1 promoter contains response elements to 
growth hormone (GH) as well as steroid hormones (androgens and 
estrogens) (Gentile et al., 2010; Hewitt et al., 2010; O'Sullivan et 
al., 2002a; O'Sullivan et al., 2002b; Ohtsuki et al., 2007) and also 
contains a binding site for MyoD (McLellan et al., 2006), 
indicating an important role for IGF-1 during myogenic 
progression. The binding of IGF-1 to its transmembrane receptor 
(IGF-1R) is a potent activator of phosphatidylinositol-3 kinase 
(PI3K)/Akt intracellular response (Oberbauer, 2013; Rommel et 
al., 2001). Activation of Akt results in the downstream activation 
of the mammalian target of rapamycin (mTOR) which stimulates 
protein synthesis and inhibits atrophy-related pathways and protein 
degradation (Bodine et al., 2001; Bonaldo and Sandri, 2013; Latres 
et al., 2005; Rommel et al., 2001). Both IGF-1 and TGFβ pathways 
regulate the PI3K/Akt/mTOR pathway (Glass, 2010): MST and 
other molecules activating the TGFβ pathway have inhibitory 
effects on PI3K/Akt/mTOR, which can be dominantly overcome 
by IGF-1 (Trendelenburg et al., 2009). Taken together, these data 
indicate that a balance between the TGFβ and IGF-1 pathways 
determines muscle homeostasis and that alterations of this balance 
can account for muscle atrophy and impaired regeneration. For this 
reason these pathways have been proposed as therapeutic targets in 
the case of several chronic diseases and muscle degenerative 
disorders. Suppression of MST or administration of soluble forms 
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of the AcvR2B triggers an increase in muscle mass and ameliorates 
prognosis of congenital myopathies, such as DMD, amyotrophic 
lateral sclerosis (ALS), as well as antagonize muscle wasting 
during sarcopenia and cancer-induced cachexia (Akpan et al., 
2009; Lawlor et al., 2011; Morrison et al., 2009; Pistilli et al., 
2011; Siriett et al., 2006; Wagner et al., 2002; Zhou et al., 2010a). 
Moreover, mice genetically over-expressing a muscle local isoform 
of IGF-1 exhibit myofiber hypertrophy, are protected against 
muscle atrophy as well as display a higher regeneration capability 
during aging (Musaro et al., 2001; Schulze et al., 2005). In addition 
to this, overexpression of IGF-1 in muscles affected by ALS is able 
to reduce catabolism and promote motoneuron survival 
(Dobrowolny et al., 2008; Dobrowolny et al., 2005; Musaro et al., 
2007; Scicchitano et al., 2009). 
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3. A specialized case of skeletal muscles: the extraocular 
muscles 
 
The extraocular muscles (EOMs) are six muscles surrounding 
the ocular globe responsible for eye movements in vertebrates 
(Bohnsack et al., 2011). These muscles do not share the same 
embryological origin with the other skeletal muscles of the body 
and display characteristics of both skeletal and cardiac muscle 
(Porter, 2002). Regarding innervation, adult mammalian skeletal 
muscles exhibit a specific pattern, with one motoneuron contacting 
several muscle fibres (the ‘motor unit’), however EOMs also 
contain 15-20% of multiply innervated myofibers (Porter et al., 
1995; Spencer and Porter, 1988). Moreover, contrary to the other 
skeletal muscles of the body, EOMs show a great heterogeneity in 
MHC isoforms expression at the single fiber level as well as 
depending on the location within the muscle (external/orbital vs. 
internal/global layers) (Porter, 2002; Zhou et al., 2010b): some 
EOM fibres retain embryonic isoforms while expressing at least 
one adult isoform (Brueckner et al., 1996; Jacoby et al., 1990) and 
some multiply innervated fibres also express α-cardiac myosin 
(Rushbrook et al., 1994). Finally, adult EOMs express EOM-
unique MHC isoform 13 (MHC13) (Brueckner et al., 1996; Porter, 
2002; Wieczorek et al., 1985). All these features probably reflect 
an evolutionary adaptation to a rapid control of eye movements as 
well as a common embryological origin with cardiac muscle 
(Porter, 2002). EOMs have drawn attention of the scientific 
community as they are selectively spared in several myopathies 
which progressively affect the other skeletal muscles of the body, 
as DMD and ALS, while they are selectively targeted by 
myopathies which do not affect the other skeletal muscles of the 
organism or only at later stages, such as the oculopharyngeal 
muscular dystrophy and myasthenia gravis (Abu-Baker and 
Rouleau, 2007; Davies et al., 2006; Khurana et al., 1995; Porter et 
al., 1995; Soltys et al., 2008). Some reports described the presence 
of activated satellite cells in uninjured normal EOMs from 
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different species (McLoon et al., 2004; McLoon and Wirtschafter, 
2002a; McLoon and Wirtschafter, 2003; McLoon and Wirtschafter, 
2002b) as well as an increase in the total number of satellite cells 
(McLoon et al., 2007), leading to the hypothesis that a continuous 
myonuclei addition to the fibres would lead to a constant 
remodelling of EOMs throughout life and could account for their 
sparing in several degenerative diseases. However none of these 
reports presents an exhaustive overlook of neither the satellite cell 
nor the entire niche status in EOMs.  
Other studies suggested that intrinsic differences in EOMs 
could account for their resistance to degenerative diseases. 
Structural intrinsic properties of the EOM fibres could in fact 
possibly prevent their degeneration during myopathies: EOM 
fibres from mdx mice retain the dystrophin-protein complex and 
are more resistant to oxidative stress (Porter et al., 2003) as well as 
to the damages caused by the excess of intracellular calcium 
observed in DMD, because of an increased capacity to regulate 
calcium homeostasis (Pertille et al., 2010; Zeiger et al., 2010). Also 
differences between EOM and limb muscle gene expression 
profiles have been found (Khanna et al., 2004; Khanna et al., 2003; 
Pacheco-Pinedo et al., 2009; Porter et al., 2006; Porter et al., 2001; 
Porter et al., 2003), for example EOMs show increased levels of 
chaperones, as well as IL-10 receptor β (IL10Rβ) and several 
molecules involved in the TGFβ pathway, as follistatin-like 1 
(Fstl-1) and TGFβ-induced protein (TGFβi) (Porter et al., 2003). 
Consistent with these data, SP cells isolated from EOMs exhibit 
increased expression of TGFβi and Fstl-1, as well as FST and bone 
morphogenetic proteins (BMPs) involved in the TGFβ pathway 
(Pacheco-Pinedo et al., 2009). In addition, differences between the 
orbital and global layers of EOMs have been also described: FST 
and IGF-binding protein-3 (IGFBP3) are more expressed in the 
orbital layer whereas MST is more expressed in the global layer 
(Khanna et al., 2004). In EOMs, TGFβ and IGF-1 pathways are 
able to trigger the same signals as in limb muscles, thus regulating 
muscle mass and force (Anderson et al., 2008; Chen and von 
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Bartheld, 2004). However, EOMs show interesting features, for 
instance Schwann cells of the EOM-related nerves constitute a 
major source of local IGF-1 for EOMs, which is anterogradely 
transported along the throclear nerve (Feng and Von Bartheld, 
2010), possibly explaining the sparing of EOMs in ALS. A 
peculiar regulation of the TGFβ and IGF-1 pathways resulting in 
favour of positive signals in normal as well as diseased EOMs may 
account for their innate resistance to muscle degenerative disorders 
and regulate EOM satellite cell specific properties. EOM satellite 
cells can efficiently differentiate into myofibers when engrafted 
into limb muscles, but the EOM satellite cell-derived fibres do not 
express MHC13 in this location, indicating that signals coming 
from the EOM niche are important to regulate EOM satellite cell 
specific phenotype (Sambasivan et al., 2009). Progenitor 
populations within the niche may be involved: interestingly, 
microarray analysis revealed that PW1/Peg3 is strongly 
upregulated in normal EOMs compared to limb muscles (Porter et 
al., 2003), suggesting a possible increase of PW1 gene expression 
or an increase of the total number of PW1-expressing cells in 
EOMs muscles. A recent study also described the isolation of a 
novel subpopulation of cells from EOMs exhibiting myogenic 
capacity in vitro: these cells were isolated within the SP and were 
positive for CD34 but negative for Sca1, satellite cell markers (i.e. 
Pax7 or M-cadherin), endothelial markers and leukocyte marker 
CD45 (Kallestad et al., 2011). These CD34+ cells were increased in 
adult wild-type EOMs compared to limb muscles, retained in aged 
EOMs as well as elevated in EOMs from mdx mice but absent in 
limb muscles from the same DMD mouse model (Kallestad et al., 
2011). However, more detailed studies on the EOM stem cell niche 
are still missing. 
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AIMS 
 
Satellite cells are the major resident progenitor population in 
postnatal skeletal muscle and they are strictly necessary for muscle 
regeneration (Relaix and Zammit, 2012), although other 
progenitors are also involved in regulating regeneration and 
probably postnatal growth (Pannerec et al., 2012). We previously 
described a subpopulation of interstitial cells expressing PW1 
(PICs), exhibiting strong myogenic capacity in vitro as well as 
after engraftment in damaged muscles in juvenile mouse muscle 
(Mitchell et al., 2010). In particular, engrafted PICs can participate 
in myofiber repair as well as repopulate the satellite cell and PIC 
niches (Mitchell et al., 2010). PICs can generate smooth muscle 
cells in addition to skeletal muscle cells in vitro (Mitchell et al., 
2010). Taken together, these data suggested that PICs and satellite 
cells are distinct and that PICs are more plastic than satellite cells. 
A recent report from our laboratory demonstrated that PW1 is a 
pan-stem cell marker in the adult (Besson et al., 2011), supporting 
the hypothesis that PW1-expressing cells in skeletal muscle are 
progenitor cells with different capacities. The first aim of this 
work was to describe postnatal muscle progenitor cell fates. We 
set up FACS conditions to isolate satellite cells and PICs from 
postnatal limb muscles using CD34 and Sca1 markers, as 
previously reported (Mitchell et al., 2010). In juvenile mice, PICs 
can be found in two populations expressing Sca1 at different levels 
(Sca1MED and Sca1HIGH): PICs are highly enriched in the Sca1MED 
population, whereas the Sca1HIGH population was mixed with PW1 
non-expressing cells (Mitchell et al., 2010). Our initial description 
of PICs was restricted to the Sca1MED fraction in juvenile mice 
(Mitchell et al., 2010). In order to characterize the PW1-expressing 
cells from the Sca1HIGH fraction in wild-type mice, we used the 
Pw1IRESnLacZ reporter mouse model generated in our laboratory 
(Besson et al., 2011). In parallel, we performed microarray 
analyses comparing juvenile Sca1MED PICs and satellite cells, 
which indicated that these two cell types have distinct 
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transcriptomes. We then systematically tested PICs (both Sca1MED 
and Sca1HIGH) differentiation capacity into several lineages in vitro 
from juvenile to adult stage, investigating other possible lineages 
not explored in previous studies. Since recent studies have 
described the presence of interstitial Sca1+ cells expressing 
PDGFRα with adipogenic capacity (IAPs) (Joe et al., 2010; 
Uezumi et al., 2010), we tested whether PICs and IAPs consisted 
of overlapping or distinct populations based upon both PDGFRα 
and adipogenic potential in vitro.  
An understanding of the muscle stem cell niche and its 
cellular components provides an important knowledge base for 
designing therapeutic approaches for a variety of muscle diseases. 
In the case of muscle degenerative diseases as well as muscle 
atrophy induced by cancer, diabetes, heart and renal failure or 
ageing, skeletal muscles undergo a loss of mass and force, 
associated with poor prognosis and death. These myopathies are 
also associated with degeneration of the myofibers and a reduction 
in satellite cell number and/or regenerative capacity, concomitant 
with fibrosis and fat deposition (Mann et al., 2011). Furthermore, 
the abnormal increase of catabolic activity observed in atrophic 
muscles leads to a profound alteration of satellite cell behavior. All 
these conditions display activation of the AcvR2B pathway 
(Serrano et al., 2011; Tabebordbar et al., 2013) and inhibition of 
this pathway reduces the loss of muscle mass and strength (George 
Carlson et al., 2011; Pistilli et al., 2011; Zhou et al., 2010a). The 
hypertrophic effect induced by AcvR2B inhibition has been 
proposed to be coupled with an activation of the satellite cell 
compartment (McCroskery et al., 2003; McCroskery et al., 2005). 
Several murine models have been generated in which the satellite 
cell compartment can be selectively depleted leading to the 
proposal that a minimal number of satellite cells is necessary for 
proper regeneration and that other progenitors cells with myogenic 
capacities, such as PICs, cannot compensate under these conditions 
(Lepper et al., 2011; Sambasivan et al., 2011b). The second aim of 
this work was to elucidate the role of PICs in adult muscle and 
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their relationships with satellite cells, in context of hypertrophy 
and regeneration. Microarray analyses revealed that effectors of the 
AcvR2B pathway are differentially regulated between PICs and 
satellite cells suggesting a crosstalk between these two cell types. 
To explore niche interactions in vivo, we used a soluble form of the 
AcvR2B, (RAP-031, Acceleron Pharma, USA) which competes 
with the endogenous AcvR2B through competitive interactions. 
Previous studies using this molecule in wild-type mice, as well as 
murine models for DMD, ALS and other muscular diseases, 
revealed that RAP-031 treatment leads to an increase in muscle 
mass and force (Akpan et al., 2009; George Carlson et al., 2011; 
Koncarevic et al., 2010; Morrison et al., 2009; Pistilli et al., 2011; 
Pistilli et al., 2010). We then analysed the effects of the blockade 
of AcvR2B pathway after RAP-031 injection on muscle niche 
progenitors (PICs and satellite cells) in wild-type adult mice. 
Moreover, as previous work demonstrated that PICs show a 
pronounced myogenic capacity in vitro and after engraftment in 
vivo (Mitchell et al., 2010), we assessed whether PICs are 
mobilized in situ under conditions in which the satellite cell 
population is depleted (Sambasivan et al., 2011b) coupled with 
AcvR2B pathway inhibition.  
While most studies have focused extensively on limb 
muscles, there are unique muscle groups that are spared in many 
degenerative diseases or affected only at very advanced stages of 
these diseases including the extra-ocular muscles (EOMs) (Porter 
et al., 1995). Understanding the intrinsic properties of EOMs may 
provide insights into endogenous protective mechanisms in skeletal 
muscle. It has been proposed that an altered stem cell niche 
underlies the resistance of EOMs in these pathologies, however, to 
date, no reports have provided a detailed characterization of EOM 
progenitor cells. Therefore the third aim of this work was to 
analyze the EOM stem cell niche in wild type and DMD model 
(mdx) mice in order to determine if variations in the number or 
activation state of PICs and satellite cells were present which could 
eventually explain EOM unique phenotype.  
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RESULTS 
 
1. Defining the muscle stem cell niche 
 
1.1. Juvenile PICs and satellite cells have distinct gene 
expression profiles 
 
We performed transcriptome analyses (Affymetrix) using 
RNA from wildtype PICs and satellite cells freshly isolated from 1 
week old murine limb muscles corresponding to a stage of active 
postnatal muscle growth. At this stage, satellite cells have not 
entered a completely quiescent state (Pallafacchina et al., 2010) 
nonetheless, PICs and satellite cells are clearly distinguishable 
based upon their location (sublaminal versus interstitial) and by the 
expression of Pax7 (satellite cells) and PW1/Peg3 (satellite cells 
and PICs) (Mitchell et al., 2010). We observed distinct 
transcriptome signatures with 1345 and 1233 genes expressed 
specifically in PICs and satellite cells respectively (Fig. 2A and 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40523). 
Gene Ontology database analyses revealed that satellite cell-
specific genes are related primarily to the skeletal muscle lineage 
(i.e. c-met, desmin). As expected, we observed the expression of 
genes known to be expressed in satellite cells and/or proliferating 
myoblasts (i.e. Pax7, MRFs, CXCR4, integrin-α7, FGFR4) 
(Fukada et al., 2007; Pallafacchina et al., 2010) (Fig. 2B). In 
contrast, PICs express genes that are associated with multiple cell 
fates including FoxC2 and ephrins (mesenchymal stem cells), 
VEGF and angiogenin (angiogenesis), and numerous genes 
governing cell interaction and cell migration (Fig. 2C,D). We 
confirmed the expression of PW1/Peg3 in both cell types  
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40523). 
We observed that specific growth factors and their cognate 
receptors were reciprocally expressed by PICs and satellite cells 
suggesting paracrine interactions between these two cell types 
(Tables 1, 2). We observed that PDGFRα was highly expressed in 
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juvenile PICs as compared to satellite cells (Table 1) suggesting 
that resident adipogenic populations (Joe et al., 2010; Uezumi et 
al., 2010) overlap with PICs. These analyses were performed using 
juvenile muscle in which the PICs and satellite cells are 
presumably not fully quiescent. We therefore verified the 
proliferative status of these populations by staining 1 week old 
hindlimb muscle for the cell cycle marker, Ki67.  We observed that 
only ~15% of PICs and ~25% of satellite cells are cycling whereas 
the majority of these cell populations are quiescent (Fig. 2E). The 
distinct gene expression profiles observed here for juvenile satellite 
cells and PICs, combined with our previous analyses 
demonstrating that PICs do not arise from a Pax3 lineage (Mitchell 
et al., 2010), support the hypothesis that PICs and satellite cells are 
distinct progenitor populations and that PICs represent a less 
committed progenitor compared to satellite cells. Furthermore, 
despite residual postnatal proliferative activity of satellite cells 
used for these analyses, we noted that the satellite cells have 
already assumed a gene expression profile closely resembling that 
found in adult satellite cells (Pallafacchina et al., 2010) (and see 
Fig. 5E). 
 
1.2. Juvenile PICs display multipotent potentials in vitro 
 
We reported previously that PICs can be enriched from 
juvenile muscle (1-2 weeks of age) by sorting for the cell surface 
markers CD34 and Sca1 (Mitchell et al., 2010). At this stage, PICs 
are present in the CD34+Sca1+ population, which can be 
subdivided into two populations based on Sca1 expression levels 
(Sca1MED and Sca1HIGH). In our previous study, we limited our 
analyses to the Sca1MED population due to the enriched number of 
PW1/Peg3 cells in this fraction (>90%) (Mitchell et al., 2010). We 
were unable to isolate the PW1/Peg3+ cells in the Sca1HIGH 
population due to a lack of appropriate markers. We have shown 
previously that the PW1nlacZ reporter mouse allows for the 
purification of PW1/Peg3 expressing cells using a fluorescent 
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substrate (C12FDG) for β−galactosidase activity from a wide array 
of tissues and that reporter expression corresponds to endogenous 
PW1/Peg3 expression with >98% fidelity in these tissues including 
skeletal muscle (Besson et al., 2011). We therefore used the 
PW1nlacZ reporter mouse to purify PW1/Peg3 expressing cells from 
juvenile muscle and observed reporter gene expression in satellite 
cells and in the Sca1MED and Sca1HIGH populations as expected 
(Fig. 3A and see (Besson et al., 2011; Mitchell et al., 2010). 
Sca1MED cells isolated from 1-week old muscle were >90% pure 
for PW1/Peg3 expression while the Sca1HIGH fraction contains only 
60% of PW1/Peg3+ cells (Fig. 3A and (Mitchell et al., 2010), 
confirming that reporter expression in skeletal muscle reflected 
faithfully endogenous PW1/Peg3 expression. We therefore used 
the PW1nlacZ reporter mouse to sort the PW1+Sca1HIGH population 
to >90% purity (Sca1HIGH PICs) (Fig. 3B). We compared and 
verified expression of a subset of genes from our microarray 
analysis in satellite cells, Sca1MED PICs, Sca1HIGH PICs, and 
Sca1HIGHPW1
- cells, from 1-week old hindlimb muscle (Fig. 3C). 
Neither population expressed the hematopoietic marker CD68, 
demonstrating the reliability of the FACS sorting (Fig. 3C). As 
expected, only the satellite cell fraction expressed Pax7, Myf5, and 
FGFR4 (Pallafacchina et al., 2010) consistent with our previous 
observations (Mitchell et al., 2010) and further demonstrating that 
the PIC fractions were not contaminated by satellite cells. We note 
that only PICs express P2Y14 and QPRT, two of the most 
represented genes specific to PICs in our micro-array analysis 
(Table 1). Interestingly, while all populations expressed the 
embryonic marker vimentin, only the Sca1HIGH PICs fraction 
expressed the mesenchymal marker Tie2, which has been shown 
recently to mark adipogenic progenitors suggesting a link between 
these populations (Uezumi et al., 2010). This correlation was 
further confirmed by the fact that PDGFRα is highly expressed in 
both PICs fractions (Fig. 3C and Table 1). We showed previously 
that Sca1MED PICs from juvenile mouse muscle are capable of 
differentiating into smooth and skeletal muscle in vitro (Mitchell et 
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al., 2010). In order to test all PW1+ populations (satellite cells, 
Sca1MED and Sca1HIGH PICs), we purified these fractions using 1-
week old PW1nLacZ reporter mice and tested their myogenic and 
adipogenic potentials (Fig. 3D,E). As expected, we observed that 
satellite cells are highly myogenic (fusion index >80%) and do not 
display detectable adipogenic capacity, whereas Sca1MED PICs 
gave rise to skeletal muscle (fusion index=40%) and smooth 
muscle cells. In addition, the Sca1MED PICs gave rise to adipocytes 
(adipogenic potential=40%) when cultured in adipogenic media 
(Fig. 3D,E). In contrast, Sca1HIGH PICs displayed lower skeletal 
myogenic (fusion index=20%) and adipogenic potentials (30%) as 
compared to Sca1MED PICs (Fig. 3D,E). We noted that all PIC 
fractions displayed smooth muscle cell fates (Fig. 3D). In contrast 
to PICs, we found that Sca1HIGH PW1
- cells adopt a smooth muscle 
phenotype but do not display myogenic nor adipogenic potential 
(Fig. 3D,E). 
 
1.3. The Sca1MED PICs population is restricted to early 
postnatal stages 
 
Having confirmed the reliability of the PW1nlacZ reporter 
mouse and our FACS protocol in juvenile skeletal muscle, we set 
out to systematically isolate and test the lineage potential of 
PW1/Peg3+ cells from both Sca1 expressing fractions throughout 
postnatal development and early adulthood. These analyses 
revealed a progressive decline of the Sca1MED fraction during the 
first 3 weeks of life such that it was no longer detectable 5 weeks 
after birth (Fig. 4A). During this period, we observed that the 
Sca1HIGH cell fraction increased from ~30% to ~70% of the CD45
-
Ter119- muscle cells (Fig. 4B). While the Sca1HIGH cells increased 
in number, the proportion of PW1/Peg3+ cells declined from ~60% 
to ~40% (Fig. 4C). We isolated  PW1+ cells in the Sca1HIGH 
fraction from 7 weeks old PW1nlacZ reporter mouse muscle using 
C12FDG as described for the juvenile muscle (Fig. 3B, 5A). We 
verified reporter and PW1/Peg3 expression in freshly sorted 
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cytospun cells as previously described (Besson et al., 2011) (Fig. 
3B). We verified Pax7 expression to confirm the purity of the 
satellite and non-satellite cell fractions (Fig. 5B). These data 
revealed that the Sca1MED population of PICs is restricted to the 
first 3 weeks of postnatal life raising the question as to what stem 
cell potential, if any, is present in the Sca1HIGH population. 
 
1.4. Adult PICs show multiple cell fates in vitro 
 
We next tested the myogenic (skeletal and smooth) and 
adipogenic potentials of all PW1/Peg3+ populations (satellite cells, 
Sca1HIGH PICs) in adult muscle (7 weeks)  (Fig. 5C).  As expected, 
adult satellite cells were highly myogenic (fusion index=80%) and 
did not form smooth muscle or fat. Adult PICs generated skeletal 
muscle (fusion index=25%), smooth muscle, and fat (adipogenic 
potential=60%) (Fig. 5C,D). In contrast, the Sca1HIGH PW1- cells 
did not show any myogenic nor adipogenic potential but adopted a 
smooth muscle-like phenotype. Semi-quantitative PCR analysis 
showed no expression of Pax7 and myogenic markers in the adult 
Sca1HIGH PICs, confirming the reliability of our purification 
protocol. We note that adult Sca1HIGH and juvenile Sca1HIGH PICs 
show a similar gene profile (Fig. 5E). Notably, both juvenile and 
adult Sca1HIGH PICs express Tie2 and PDGFRα, consistent with an 
adipogenic potential (Uezumi et al., 2010; Uezumi et al., 2011) 
(Fig. 3C and 5E). We next examined whether cell fate potentials of 
PICs changed during the juvenile to adult transition. We found that 
the PW1/Peg3- cells do not display myogenic nor adipogenic 
capacity at all stages examined (Figs. 6-8). Up to 3 weeks of 
postnatal development, when the Sca1MED PIC population is still 
detectable, we find this fraction retains the capacity to form fat and 
skeletal muscle (Figs. 6, 7). While the Sca1HIGH PIC population 
also shows a similar cell fate potential, we noted that this fraction 
was more adipogenic (Figs. 6, 7). At 5 weeks, when we no longer 
detect the Sca1MED PICs, we observed a much higher skeletal 
myogenic capacity (~20%) in the Sca1HIGH PIC population (Fig. 8) 
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similar to what we observed at 7 weeks of age. Taken together, 
these results demonstrate that PW1/Peg3 identifies multiple 
progenitor populations in adult and juvenile skeletal muscle. 
 
1.5. Adult PICs are composed of two subpopulations 
 
Adult skeletal muscle contains resident progenitor cells that 
can adopt an adipogenic fate under pathological conditions (Joe et 
al., 2010; Uezumi et al., 2010). These adipogenic progenitors had 
been isolated previously based upon Sca1 expression (Joe et al., 
2010) or coexpression of Sca1 and PDGFRα (Uezumi et al., 2010). 
The potential overlap of these interstitial adipogenic progenitors 
(referred to here as IAPs) had not been elucidated, however the 
population of Sca1+PDGFRα+ cells is presumably contained within 
the Sca1+ population. We observed that both juvenile and adult 
PICs expressed high levels of PDGFRα and display significant 
adipogenic potential (Figs. 3, 5). We therefore determined whether 
PICs and IAPs represent distinct or overlapping populations in the 
adult. Histological analyses of 7-weeks old mouse tibialis anterior 
revealed that PW1/Peg3 was co-expressed with PDGFRα in 
interstitial cells, however not all PW1/Peg3+ cells express 
PDGFRα (Fig. 9A). As reported by Uezumi and colleagues 
(Uezumi et al., 2010), and confirmed in our studies here (Figs. 3C 
and 5E), PDGFRα expression is restricted to the Sca1+ cells in 
muscle. We therefore isolated PDGFRα positive and negative cells 
from the total Sca1HIGH fraction to assess PW1/Peg3 expression 
(Fig. 9B). Immunostaining for PW/Peg3 and PDGFRα on freshly 
isolated cells revealed that all PDGFRα+ cells in the Sca1HIGH 
fraction expressed PW1/Peg3 whereas the PDGFRα negative cells 
from the Sca1HIGH fraction contained a small proportion of cells 
expressing PW1/Peg3 (12% ±0,9) (Fig. 9E). We next tested the 
Sca1HIGHPDGFRα+ and Sca1HIGHPDGFRα
- populations for 
myogenic and adipogenic potential and observed that adipogenic 
potential was restricted to the Sca1HIGHPDGFRα+ population (Fig. 
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9C,D) consistent with previously reported results (Uezumi et al., 
2010). The Sca1HIGHPDGFRα
- population did not display any 
myogenic nor adipogenic potential. We next separated the 
Sca1HIGH population on the basis of PW1/Peg3 reporter gene 
expression and PDGFRα to obtain PDGFRα+ and PDGFRα- PICs 
(Fig. 10A). As expected, the PDGFRα+ PICs did not form any 
myogenic colonies but were strongly adipogenic (adipogenic 
potential=60%) (Fig. 10B,C). These differentiated adipocytes 
expressed genes related to adipogenesis (FABP4/aP2) as well as 
genes specific to brown adipose tissue specific markers (Ucp1, 
Prdm16) and white/‘beige’ fat (Hoxc9) (Fig. 10F). In contrast, the 
PDGFRα- PICs were highly myogenic (fusion index=50%) but did 
not display adipogenic capacity (Fig. 10B,C). Fraction purity was 
confirmed by immunofluorescence for Pax7 and PW1/Peg3 on 
freshly sorted cytospun cells (Fig. 10D) as well as by semi-
quantitative PCR on freshly sorted cells (Fig. 10E). All PIC 
populations were negative for Pax7 and myogenic genes. Only the 
PDGFRα+ PICs express the adipogenic markers Tie2 and 
PDGFRα, as expected. Taken together, these results demonstrate 
that adult PICs can be separated by PDGFRα expression into two 
distinct populations with different cell fate potentials. 
We have shown that adult PICs and juvenile Sca1MED and 
Sca1HIGH PICs express PDGFRα, while only adult and juvenile 
Sca1HIGH PICs express Tie2 (Fig 3C and 5E).	   We therefore 
separated juvenile (1 week) Sca1MED and Sca1HIGH PICs based on 
PDGFRα expression and tested their myogenic and adipogenic 
potentials. As expected, only the PDGFRα- fractions (Sca1MED and 
Sca1HIGH) displayed myogenic capacity (Fig. 11). Surprisingly, the 
juvenile Sca1MEDPDGFRα+ cells were weakly adipogenic (~5%) 
(Fig.11) as compared to the total Sca1MED fraction (~35% 
adipogenic potential, Fig. 3D,E), suggesting that cell-cell 
interactions regulate cell fate outcomes. Juvenile 
Sca1HIGHPDGFRα+ PICs, like adult Sca1HIGHPDGFRα+ PICs, were 
strongly adipogenic (~40% adipogenic potential) (Fig.11).  
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Figure 2. PICs and satellite cells are distinct progenitors. (A) Venn diagram 
presenting the gene distribution of PICs and satellite cells. Data were obtained 
from Affymetrix micro-array analysis of 1-week old C57bl6 mice with n=3 for 
each population. Fold Change threshold=1, p-value=0,01. Gene Ontology 
clustering analysis for Skeletal Muscle (B), Mesenchymal Cell Development (C) 
and Angiogenesis (D) gene categories. The gene tree is shown on the left and 
gene coloring was based on normalized signals as shown in the color bar. (E) (i) 
Cross-section of 1-week old hindlimb muscle from C57Bl6 mice stained for 
PW1 (green) and the proliferation marker Ki67 (red). Laminin staining (orange) 
shows the basal lamina. Nuclei were counterstained by DAPI (blue). Arrows 
indicate proliferative PICs, arrowheads indicate quiescent PICs. Scale bar, 
20µm. (ii) Quantification of proliferative (Ki67+) PICs (gray) and satellite cells 
(black) for 1 week old mice from cross sections stained as shown in (i). Values 
represent the mean number of positive satellite cells or PICs ± s.e.m. per 100 
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cells respectively. At least 500 cells for each cell types from 3 independent 
experiments were counted. 
 
Table 1. Genes preferentially expressed by PICs. For each gene, the average 
expression intensity was calculated from Affymetrix analysis. Fold change and 
p-value are indicated. 
 
Gene 
symbol 
Gene name Average 
intensity 
Fold 
Change 
p-value 
  PICs SAT   
Qprt quinolinate phosphoribosyltransferase 793 14 -62.7 0.0027 
P2ry14 purinergic receptor P2Y, G-protein coupled, 14 1477 32 -46.5 0.0005 
Itgb3 integrin beta 3 518 14 -41.4 0.0019 
Apod apolipoprotein D 1403 39 -39.1 0.0077 
Gpr133 G protein-coupled receptor 133 438 13 -35.6 0.0025 
Aldh1a2 aldehyde dehydrogenase family 1, subfamily A2 1444 49 -35.4 0.0048 
Myoc myocilin 1549 50 -35.2 0.0035 
Adam33 a disintegrin and metallopeptidase domain 33 398 13 -34.8 0.0043 
Fst follistatin 381 11 -32.8 0.0073 
Foxd1 forkhead box D1 724 21 -32.4 0.0025 
Ptch2 patched homolog 2 840 35 -31.8 0.0094 
Il1rl2 interleukin 1 receptor-like 2 499 19 -29.3 0.0027 
Pdgfra platelet derived growth factor receptor, alpha 
polypeptide 
897 124 -28.3 0.0016 
Ebf2 early B-cell factor 2 224 8 -28.1 0.0005 
Gjb2 gap junction membrane channel protein beta 2 950 35 -27.3 0.0013 
Vtn vitronectin 1201 49 -26.2 0.0023 
Il15 interleukin 15 204 8 -25.6 0.0005 
Cd55 CD55 antigen 438 18 -25.2 0.0015 
Mmp16 matrix metallopeptidase 16 892 44 -23.3 0.0066 
Arhgap20 Rho GTPase activating protein 20 473 24 -22.8 0.0041 
Dnm1 dynamin 1 1517 91 -19.8 0.0084 
Avpr1a arginine vasopressin receptor 1A 331 20 -19.4 0.0088 
Adra2a adrenergic receptor, alpha 2a 369 21 -18.8 0.0040 
Bmp7 bone morphogenetic protein 7 123 6 -18.2 0.0025 
Wnt5a wingless-related MMTV integration site 5A 1293 75 -18.1 0.0018 
Ednra endothelin receptor type A 261 15 -17.7 0.0026 
Ephb2 ephrin receptor B2 300 19 -16.7 0.0030 
Pi15 Peptidase inhibitor 15 171 12 -16.6 0.0083 
Fgf1 fibroblast growth factor 1 462 31 -16.6 0.0060 
Twist1 twist gene homolog 1 (Drosophila) 523 33 -16.5 0.0018 
Negr1 neuronal growth regulator 1 136 8 -16.4 0.0012 
Lepr leptin receptor 173 11 -16.2 0.0013 
Twist2 twist homolog 2 (Drosophila) 114 7 -16.1 0.0013 
Efnb1 ephrin B1 315 46 -6.7 0.0013 
NG2 chondroitin sulfate proteoglycan 4 965 153 -5.9 0.0107 
Pdgfrb platelet derived growth factor receptor, beta 
polypeptide 
4916 1050 -4.8 0.0089 
Tgfbr2 transforming growth factor, beta receptor II 9019 2521 -3.6 0.0023 
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Table 2. Genes preferentially expressed by satellite cells. For each gene, the 
average expression intensity was calculated from Affymetrix analysis. Fold 
change and p-value are indicated. 
Gene 
symbol 
Gene name Average 
intensity 
Fold 
Change 
p-value 
  PICs SAT   
Gpr50 G-protein-coupled receptor 50 10 1012 117.6 0.0016 
Fgfr4 fibroblast growth factor receptor 4 13 1032 86.5 0.0048 
Ryr1 ryanodine receptor 1, skeletal muscle 8 640 80.8 0.0019 
Chrna1 cholinergic receptor, nicotinic, alpha 
polypeptide 1 (muscle) 
75 4851 74.8 0.0028 
Pitx3 paired-like homeodomain transcription 
factor 3 
4 310 68.9 0.0005 
Myod1 myogenic differentiation 1 47 2275 57.1 0.0036 
Sgca sarcoglycan, alpha (dystrophin-
associated glycoprotein) 
6 350 55.6 0.0002 
Cdh15 cadherin 15 59 2648 55.3 0.0040 
Lbx1 ladybird homeobox homolog 1 
(Drosophila) 
7 332 48.4 0.0007 
Tnnt2 troponin T2, cardiac 23 989 44.5 0.0014 
Pitx2 paired-like homeodomain transcription 
factor 2 
8 329 42.6 0.0007 
Traf3ip3 TRAF3 interacting protein 3 21 891 41.6 0.0004 
Lama5 laminin, alpha 5 13 364 33.8 0.0090 
Pde1c phosphodiesterase 1C 6 166 26.6 0.0005 
Arpp21 cyclic AMP-regulated phosphoprotein, 
21 
13 349 26.1 0.0005 
Atp2a1 ATPase, Ca++ transporting, cardiac 
muscle, fast twitch 1 
64 1481 22.4 0.0022 
Tnik TRAF2 and NCK interacting kinase 28 593 22.0 0.0041 
Myh3 myosin, heavy polypeptide 3, skeletal 
muscle, embryonic 
18 378 21.3 0.0016 
Neb nebulin 7 155 21.1 0.0002 
Dcx doublecortin 10 194 19.5 0.0046 
Ephb1 ephrin receptor B1 8 124 16.0 0.0016 
Chrng cholinergic receptor, nicotinic, gamma 
polypeptide 
8 134 15.8 0.0031 
Myh8 myosin, heavy polypeptide 8, skeletal 
muscle, perinatal 
21 289 15.5 0.0077 
Ank1 ankyrin 1, erythroid 88 1245 15.4 0.0035 
Pdgfa platelet derived growth factor, alpha 
polypeptide 
125 1532 13.7 0.0095 
Ppargc1b peroxisome proliferative activated 
receptor, gamma, coactivator 1 beta 
12 154 13.3 0.0025 
Edn3 endothelin 3 7 109 13.0 0.0089 
Tbx1 T-box 1 9 109 11.7 0.0008 
Hdac11 histone deacetylase 11 53 520 9.8 0.0009 
Des desmin 52 442 8.6 0.0091 
Gdf15 growth differentiation factor 15 45 390 8.6 0.0074 
Drp2 Dystrophin related protein 2 73 563 8.3 0.0066 
Tpm2 tropomyosin 2, beta 17 134 8.1 0.0019 
Acvr2b activin receptor IIB 21 159 8.2 0.0148 
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Figure 3. Juvenile PICs display multiple potentials in vitro. (A) Flow 
cytometric analyses of single cells from 1-week old PW1nLacZ mice limb muscles 
stained with antibodies against Sca1 and CD34. CD45 and Ter119HIGH cells 
were excluded as described previously (Mitchell et al., 2010). The gates used to 
isolate CD34-Sca1-, CD34+Sca1-, CD34+Sca1MED and CD34+Sca1HIGH cells are 
shown (i). The four fractions are indicated directly on the scatter plot (i). 
Reporter expression for each population was confirmed by β -galactosidase 
staining on freshly sorted cytospun cells and the percentage of β -galactosidase 
positive (β-gal+) cells was counted (ii). (B) The CD34+Sca1HIGH population was 
sorted based on β-galactosidase expression (i). PW1 expression was confirmed 
by immunofluorescence on freshly sorted β -gal+ and β-gal- cells and the 
percentages of PW1 expressing cells were counted. The CD34+Sca1HIGH β-gal+ 
fraction was ~ 94% positive for PW1 (ii). (C) Semi-quantitative PCR of selected 
genes from our microarray analysis in satellite cells (SAT), Sca1MED PICs, 
Sca1HIGH PICs, and Sca1HIGHPW1
- cells freshly sorted as described above. (D) 
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Representative images of FACS isolated populations grown in myogenic or 
adipogenic conditions and immunostained for the smooth muscle marker, 
SM22α (top panel), myogenic markers (MyoD, MF20, middle panels) or stained 
with Oil red O for adipocytic differentiation (bottom panel). Scale bars, 20µm. 
(E) Quantitative analysis of myogenic and adipogenic potential of cells treated 
as described in (D). Myogenic values show the mean percentage ± s.e.m. of 
nuclei incorporated into MHC+ cells. Adipogenic values show the percentage of 
Oil red O positive cells. For all graphs, values are presented as percentage of 
positive cells ± s.e.m. from at least 3 independent experiments. 
 
 
 
 
 
Figure 4. FACS profiles of muscle cells during 1-7 weeks postnatal life. (A) 
FACS profile of muscle cells from 1, 2, 3, 5 and 7-week old PW1nLacZ mice limb 
muscles. (B) Distribution of cell populations described in (A) presented as the 
mean percentage ± s.e.m. of CD45-Ter119- cells from at least 3 independent 
experiments. (C) Quantification of cells positive for PW1 in each population 
described in (A) on freshly sorted cytospun cells presented as the mean 
percentage ± s.e.m. from at least 3 independent experiments. 
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Figure 5. Adult PICs show multiple lineage capacities. (A) Flow cytometric 
analyses of single cells from 7-week old PW1nLacZ mice limb muscles stained for 
CD45, Ter119, CD34, Sca1 and C12FDG. The gates used to isolate CD34+Sca1
- 
(SAT), CD34+Sca1HIGHPW1+ (PW1+) and CD34+Sca1HIGHPW1
- (PW1-) 
populations are shown. (B) Histochemical (i) and immunolocalization (ii) of 
PW1 (green) and Pax7 (red) in freshly sorted cytospun cell fractions, as shown 
in (a). Nuclei are shown by DAPI staining (blue). Secondary antibodies controls 
are shown (ii, right panels). Scale bars, 30µm. (C) Representative images of 
FACS isolated populations grown in myogenic or adipogenic conditions and 
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immunostained for the smooth muscle marker (SM22α, top panel) and 
myogenic markers (MyoD, MF20, middle panels) or histochemically stained for 
adipocytic differentiation (Oil red O, bottom panel). Nuclei were counterstained 
by DAPI or haematoxylin. Scale bars, 20µm. (D) Quantitative analysis of 
myogenic and adipogenic potential of cells treated as described in (C). 
Myogenic values show the mean percentage ± s.e.m. of nuclei incorporated into 
MHC+ cells. Adipogenic values show the percentage of Oil red O positive cells. 
(E) Semi-quantitative PCR of selected genes from the microarray analysis in 
freshly sorted cells fractions, as shown in (A). 
 
 
Figure 6. Cell fate 
potentials of 2-weeks old 
muscle cells. (A) 
Representative images of 
FACS isolated 
populations from 2-week 
old PW1nLacZ mice 
immunostained for 
smooth muscle marker (α-
sma, top panel), myogenic 
markers (MyoD, MF20, 
middle panels), or 
histochemically stained 
for adipocytic 
differentiation (Oil red O, 
bottom panel). Nuclei 
were counterstained by 
DAPI or haematoxylin. 
Scale bars, 20µm. (B) In 
vitro myogenic and 
adipogenic potential of 
cells presented in (A). 
Myogenic potential was assessed by fusion index after 1 week in GM followed 
by 2 days in DM, and adipogenic potential was assessed by the percentage of 
adipocytes after 1 week in GM followed by 5 days in ADM. Values are 
presented as percentage of positive cells ± s.e.m. from at least n=3 independent 
experiments. 
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Figure 7. Cell fate potentials of 
3-weeks old muscle cells. (A) 
Representative images of FACS 
isolated populations from 3-week 
old PW1nLacZ mice immunostained 
for smooth muscle marker (α-sma, 
top panel), myogenic markers 
(MyoD, MF20, middle panels), or 
histochemically stained for 
adipocytic differentiation (Oil red 
O, bottom panel).  Nuclei were 
counterstained by DAPI or 
haematoxylin. Scale bars, 20µm. 
(B) Quantification of myogenic 
and adipogenic potentials of cells 
treated as described in (A). Values 
are presented as percentage of 
positive cells ± s.e.m. from at least 
3 independent experiments for 
each condition. 
 
 
Figure 8. Cell fate potentials of 5-weeks 
old muscle cells. (A) Representative images 
of FACS isolated populations from 5-week 
old PW1nLacZ mice immunostained for 
smooth muscle marker (α-sma, top panel), 
myogenic markers (MyoD, MF20, middle 
panels), or histochemically stained for 
adipocytic differentiation (Oil red O, bottom 
panel).  Nuclei were counterstained by 
DAPI or haematoxylin. Scale bars, 20µm. 
(B) Quantification of myogenic and 
adipogenic potentials of cells treated as 
described in (A). Values are presented as 
percentage of positive cells ± s.e.m. from at 
least 3 independent experiments for each 
condition. 
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Figure 9. IAPs constitute a sub-population of PICs. (A) Cross-section of a 7-
week old Tibialis anterior muscle immunostained for PW1 (green), PDGFRα 
(red), laminin (orange). Nuclei were counterstained by DAPI (blue). Species-
specific antibodies controls are shown. Arrows: PDGFRα+ cells. Arrowheads: 
PICs which do not express PDGFRα. (B) FACS isolation of PDGFRα+ and 
PDGFRα- cells from 7-week old Sca1HIGH cells. (C) Representative images of 
FACS sorted populations cultured under myogenic or adipogenic conditions, 
immunostained for the myogenic marker (MF20, top panels) or histochemically 
stained for adipocytic differentiation (Oil red O, bottom panel). (D) 
Quantification of myogenic and adipogenic potentials of cells treated as 
described in (C). Values represent the mean ± s.e.m., n = 3 independent 
Dottorato di ricerca in Scienze Morfogenetiche e Citologiche 
 Pag. 53  
experiments for each condition. Scale bars, 20µm. (E) (i) Immunolocalization of 
PW1 (green) and PDGFRα (red) in freshly sorted cytospun cell fractions, as 
shown in (B). Nuclei were counterstained by DAPI (blue). Negative controls are 
shown. (ii) Quantification of cells positive or negative for PW1 and PDGFRα. 
Values show the mean percentage ± s.e.m. of positive cells from 3 independent 
experiments. 
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Figure 10. Adult PICS cell fate can be identified by PDGFRα  expression. 
(A) FACS isolation of PDGFRα+ and PDGFRα- cells from 7-week old Sca1HIGH 
PW1+ fraction. (B) Representative images of FACS sorted populations cultured 
under myogenic (top panel) or adipogenic (bottom panel) conditions, 
immunostained for the myogenic marker (MF20, top panels) or histochemically 
stained for adipocytic differentiation (Oil red O, bottom panel). Nuclei were 
counterstained by DAPI or haematoxylin. Scale bars, 20µm. (C) Quantification 
of myogenic and adipogenic potentials of cells treated as described in (B). 
Values are presented as percentage of positive cells ± s.e.m. from at least 3 
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independent experiments for each condition. (D) Immunolocalization of PW1 
(green) and Pax7 (red) in freshly sorted cytospun cell fractions, as shown in (A). 
Nuclei are shown by DAPI staining. Secondary antibodies controls are shown. 
(E) Semi-quantitative PCR of selected genes from microarray analysis in freshly 
sorted cells fractions, as shown in (A). (F) Semi-quantitative PCR of adipocyte 
specific genes in FACS sorted populations cultured under adipogenic conditions. 
 
 
 
 
Figure 11. PDGFRα  
expression is absent 
in myogenic juvenile 
PICs. (A) Isolated 
juvenile PICs 
populations separated 
on the basis of 
PDGFRα expression 
grown in myogenic 
(top panel) or 
adipogenic (bottom 
panel) conditions. 
Scale bars, 20µm. (B) 
Quantification of 
myogenic and 
adipogenic potentials 
of cells presented in (A). Values are presented as percentage of positive cells ± 
s.e.m. from at least 3 independent experiments. 
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2. Targeting the muscle stem cell niche interactions 
 
2.1. PICs promote satellite cell proliferation via TGFβ  and 
IGF-1 pathways 
 
As outlined in the previous chapter, we reported that PICs 
and satellite cells display distinct transcriptome signatures. 
Detailed examination of these transcriptomes revealed that 
follistatin (FST) and insulin-like growth factor 1 (IGF-1) are 
expressed by PICs but not by satellite cells (Fig. 12A,B). 
Furthermore, AcvR2A is expressed by PICs, whereas AcvR2B and 
IGF-1R are expressed by satellite cells (Fig. 12A,B). These data 
suggest an interaction between PICs and satellite cells in which 
PICs secrete promyogenic factors and block myostatin activity. To 
test this hypothesis, we cultured freshly isolated adult satellite cells 
(SAT) in the presence or absence of PICs plated in the upper 
chamber of a semipermeable membrane insert system allowing for 
diffusion of secreted factors (Fig. 12C). Consistent with previous 
studies (Amthor et al., 2009; Langley et al., 2002; McCroskery et 
al., 2003), we observed that satellite cell proliferation was inhibited 
by MST in a dose-dependent manner (Fig. 12D). This inhibition 
was reversed when satellite cells were grown in the presence of 
PICs and even at high doses of MST (200 ng/ml and 2 mg/ml), the 
presence of PICs rescued satellite cell proliferation to levels 
comparable to normal growing conditions (Fig. 12D). Adding 
specific blocking antibodies for follistatin (αFST) resulted in a 
significant reduction of satellite cell proliferation at 200 ng/ml and 
2 mg/ml of MST (Fig. 12D). We observed a similar inhibition of 
the PIC-mediated rescue of satellite cell proliferation at 200 ng/ml 
of MST when using specific blocking antibodies for IGF-1 
(αIGF1) (Fig. 12D). While a previous study has shown that MST 
is localized to satellite cells (McCroskery et al., 2003) and since 
MST is not represented in the Affymetrix chip used for 
transcriptome analyses, we measured MST levels and confirmed 
FST and IGF-1 expression in freshly purified adult satellite cells, 
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PDGFRα+ PICs, PDGFRα- PICs as well as Sca1+PW1- cells, 
sorted as previously described (Mitchell et al., 2010) (Fig. 12E). 
We found that FST and IGF1-IEa were strongly expressed by 
PDGFRα+ PICs whereas MST and AcvR2B were specifically 
expressed in satellite cells (Fig. 12E). These data demonstrate that 
PICs produce pro-myogenic factors (FST and IGF-1) that 
antagonize MST activity and provide a mechanistic basis for the 
promyogenic effect exerted by FAPs (Joe et al., 2010). 
 
2.2. Inhibition of AcvR2B pathway in vivo targets the muscle 
stem cell niche 
 
It has been shown previously that a soluble form of the 
AcvR2B (RAP-031) containing the ligand-binding site is able to 
block AcvR2B mediated responses in vivo (Akpan et al., 2009; 
George Carlson et al., 2011; Koncarevic et al., 2010; Pistilli et al., 
2011). To determine whether crosstalk between PICs and satellite 
cells occurs in vivo, we injected RAP-031 twice a week for 2 
weeks, in 5 weeks old C57Bl6 male mice as described previously 
(Akpan et al., 2009; George Carlson et al., 2011) (Fig. 13A). RAP-
031-treated mice displayed a marked increase in body weight as 
compared to vehicle injected controls, comparable to the increase 
in body weight seen in age-matched MST mutant mice (Mst-/-) 
(CTL=18.38g±2.05; RAP-031=43.61g±3.82l; Mst-/-=52.84g±2.85. 
CTL vs RAP-031 p=0.0002; CTL vs Mst-/- p<0.0001). Analyses of 
the Tibialis Anterior (TA) muscles showed a marked weight and 
fiber size increase comparable to Mst-/- mice (Fig. 13B,C). 
Interestingly, we noted that increases in weight and fiber size were 
accompanied by an increase in the interstitial and sublaminal 
nuclei only following RAP-031 treatment whereas no significant 
change in the interstitial cells was observed in the Mst-/- TA 
however we noted a significant decrease in the sublaminal nuclei 
in Mst-/- TA (Fig. 13D,E). We noted that in all cases, the overall 
sublaminal/interstitial nuclei ratio remained constant (Fig. 13F) 
suggesting that cell populations are tightly controlled in adult 
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muscle. To determine whether muscle progenitor cell number was 
affected by interfering with the AcvR2B-mediated pathway, we 
measured PICs and satellite cell number by immunostaining for 
PW1 and Pax7. In Mst-/- TA muscles, we noted a significant 
increase in the number of satellite cells and PICs (2- and 3-fold 
respectively) compared to wildtype. In contrast, RAP-031 
treatment resulted in a larger increase in the number of satellite 
cells and PICs (2.5- and 4-fold respectively) (Fig. 13G). Satellite 
cells and PICs are normally present at a 1/1 ratio (Fig. 13H and 
(Mitchell et al., 2010). We note that loss of Mst or treatment with 
RAP-031 resulted in a higher proportion of PICs (Fig. 13H). 
Similar results were obtained in gastrocnemius, plantaris and 
soleus muscles from RAP-031-treated mice (data not shown). 
These data suggest that inhibition of the AcvR2B pathway induces 
proliferation of the progenitor populations in skeletal muscle, 
therefore we stained TA cross-sections for the cell cycle marker, 
Ki67. As expected, the majority of the satellite cells and PICs were 
mitotically quiescent in control mice(Pallafacchina et al., 2010) 
(Fig. 13I). RAP-031 treatment resulted in a significant increase in 
satellite cells and PICs proliferation (Fig. 13I). Taken together, we 
conclude that inhibition of the AcvR2B pathway increases the 
number of muscle progenitors, however the PIC population 
undergoes a larger expansion and alters the PIC/satellite cell ratio. 
 We demonstrated previously that PICs can generate skeletal 
muscle when cultured or directly engrafted into injured limb 
muscle (Mitchell et al., 2010). We therefore sought to determine 
whether PICs contribute to fiber hypertrophy by entering the 
skeletal muscle lineage and fusing with existing fibers. To 
distinguish between satellite cell and non-satellite cell myonuclear 
contribution during hypertrophy, we used an inducible satellite 
cell-depleted mouse model in which the diphteria toxin (DT) 
receptor is expressed under the control of Pax7 promoter so that 
DT injection induces the depletion of satellite cells as previously 
described (Pax7DTR/+ mice)(Sambasivan et al., 2011b). Pax7DTR/+ 
mice were injected with DT in the TA and PBS in the contralateral 
Dottorato di ricerca in Scienze Morfogenetiche e Citologiche 
 Pag. 59  
muscle as a control and allowed to recover for 2 weeks prior to 
RAP-031 treatment (Fig. 14A). In all cases, RAP-031 induced 
muscle fiber hypertrophy (Fig. 14B,C). Consistent with previous 
results (McCarthy et al., 2011), we observed an increase in 
myonuclei number concomitant with fiber hypertrophy in control 
muscle (satellite cell intact), whereas fiber hypertrophy still 
occurred in the absence of an increase in myonuclei number in the 
satellite cell-depleted TAs in response to RAP-031 treatment (Fig. 
14D). These data reveal that RAP-031 does not result in a 
recruitment of PICs into the myofibers during hypertrophy in the 
absence of satellite cells. Since we demonstrated that RAP-031 
treatment induces an increase in satellite cells and PICs, we sought 
to determine whether PICs and the few remaining satellite cells 
following depletion were similarly affected. We therefore stained 
muscle tissue sections from PBS or DT-injected muscles from both 
control or RAP-031 treated mice for PW1 (to label both PICs and 
satellite cells) and M-Cadherin (to label satellite cells) (Fig. 14E). 
As expected, few satellite cells survive DT injection (Sambasivan 
et al., 2011b) and we did not see any change in satellite cell 
number following RAP-031 treatment  (Fig. 14E). As shown 
previously (Sambasivan et al., 2011b) and observed here, PICs are 
easily detectable following satellite cell depletion (Fig. 14F). 
Surprisingly, we observe that PICs undergo an even greater 
increase in cell number in satellite cell depleted muscle in response 
to RAP-031 (Fig. 14F). We conclude that in the absence of 
satellite cells, RAP-031 treatment induces an increase in the PIC 
population but PICs are unable to neither replace the satellite cell 
pool nor contribute directly to myofibers.   
  
2.3. Targeting the AcvR2B pathway rescues proper 
regeneration in satellite cell-depleted muscles.  
 
Our previous data demonstrating that PICs can enter the 
myogenic lineage were obtained in culture conditions or following 
engraftment into injured muscle (Mitchell et al., 2010 and Figs. 3, 
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5). It has been shown previously that muscle regeneration is 
severely compromised in the Pax7DTR/+ model even though 3-5% 
of the satellite cell population is still present (Sambasivan et al., 
2011b). Here we demonstrated that PICs promote satellite cell 
proliferation via FST and IGF-1 secretion (Fig. 12D) and undergo 
a marked increase in number following RAP-031 treatment even in 
satellite cell-depleted muscle (Fig. 14F). To test whether the 
increase in PICs following RAP-031 treatment leads to a more pro-
myogenic microenvironment and either rescue the small number of 
remaining satellite cells and/or promote the recruitment of resident 
non-satellite cell myogenic progenitors, we crossed Pax7DTR/+ mice 
with Tg:Pax7CreERT2 mice (Mourikis et al., 2012) and with 
reporter line Rosa26mTomatoSTOPmGFP. The resulting 
Pax7DTR/+:Pax7CreERT2:Rosa26mTomatoSTOPmGFP mice express a 
tamoxifen-inducible Cre (Metzger and Chambon, 2001) so that 
Pax7-expressing satellite cells and their progeny are marked by 
GFP (Mourikis et al., 2012). Young adult mice were first injected 
with tamoxifen to activate mGFP expression in satellite cells 
followed by a single injection of DT in the right TA and PBS in the 
contralateral muscle 4 weeks after the last tamoxifen injection. 
Muscles were allowed to recover for 2 weeks and then treated with 
RAP-031. Muscles were injured by cardiotoxin one day before the 
last RAP-031 injection and the level of regeneration was assessed 
2 weeks later (Fig. 15A). As expected, all RAP-031-treated (n=9) 
and untreated (n=9) TA muscles injected with PBS showed robust 
myofiber regeneration while satellite cell depletion severely 
compromised regeneration coupled with fat deposition and fibrosis 
(Fig. 15B). In 2 of the 5 vehicle injected mouse muscles in which 
the satellite cells were depleted, we observed rare and highly focal 
areas of newly regenerated fibers suggesting that the few surviving 
satellite cells can be mobilized but cannot extend into neighbouring 
muscle tissue. In contrast, RAP-031 treatment of satellite cell 
depleted muscles resulted in a marked increase in overall 
regeneration coupled with a marked reduction of fat and fibrosis in 
7 out of 9 samples. We note that while RAP-031 treatment results 
Dottorato di ricerca in Scienze Morfogenetiche e Citologiche 
 Pag. 61  
in a marked recovery of regeneration in the satellite cell depleted 
muscle, depletion of satellite cells in vehicle injected mice resulted 
in a strong decrease of the number of centrally nucleated fibers 
after injury compared to muscles injected with PBS (8.8-fold), 
whereas this decrease was less than 1.5-fold in RAP-031 mice 
injected with DT as compared to muscles from vehicle injected 
with PBS from vehicle treated mice (Fig. 15C).  
The Pax7DTR/+:Pax7CreERT2:Rosa26mTomatoSTOPmGFP mice 
provides a genetic tool to determine if newly regenerated fibers 
derive from remaining satellite cells as these fibers are predicted to 
express mGFP whereas the presence of mGFP-mTomato+ 
regenerating fibers would indicate a contribution of unlabelled 
satellite cells or other non-satellite progenitor cells. In satellite cell-
depleted muscles from RAP-031 mice, we observed that more than 
80% of centrally nucleated fibers were mGFP+, comparable to 
CTL PBS and RAP-031 PBS conditions (Fig. 16A,B). 
Interestingly, in RAP-031 PBS TA muscles we found a 10% 
significant decrease of mGFP+ centrally nucleated fibers as 
compared to PBS injected TA (Fig. 16B), concomitant with an 
increase of mGFP-mTomato+ centrally nucleated fibers (Fig. 16B), 
suggesting that RAP-031 favors the mobilization of non-satellite 
cells over satellite cells in the context of myofiber repair. The 
presence of mTomato labeled fibers may result either from a non-
satellite cell population or reflect a small number of satellite cells 
that did not efficiently recombine to initiate GFP expression. 
Surprisingly, we observed very few satellite cells in DT TAs from 
RAP-031 mice and no significant increase in their number as 
compared to DT TAs of vehicle injected mice (Fig. 16D). These 
data reveal that inhibition of the AcvR2B pathway activates the 
few satellite cells spared by DT-mediated depletion and recruit 
them into new myofibers, however additional factors are needed in 
order to restore the satellite cell pool.  
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Figure 12. PICs antagonize the inhibitory effects of myostatin via TGFβ  
and IGF-1 pathways. (A-B) Gene Ontology clustering analyses of the TGFβ 
pathway (A) and IGF-1 pathway (B) genes. Heatmap colors reflect normalized 
signals as shown in the color bar. The gene tree is shown on the left and fold-
change and p-value are indicated for each gene. (C) Schematic transwell 
membrane system used: PICs (green) were plated in the upper well on a 
semipermeable membrane (insert) and satellite cells (red) were plated in the 
lower chamber. (D) Quantitative analyses of satellite cell proliferation in growth 
medium containing 0, 20, 200 ng/ml or 2 µg/ml of recombinant myostatin. 
Satellite cells were cultured alone (red bars) or in the presence of PICs and 
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isotype-matched IgG (grey bars). Satellite cells and PICs were co-cultured in 
presence of a blocking antibody to follistatin (αFST, blue bars) or to IGF-1 
(αIGF-1, black bars) or blocking antibodies to IGF-1 and FST together (αFST + 
αIGF1, white bars). Large colonies (>12 cells) were counted and shown as a 
percentage of the number of total colonies. (E) Semi-quantitative PCR of 
selected genes from the microarray gene list in freshly sorted adult satellite cells 
(SAT), PDGFRα+ PICs, PDGFRα- PICs and Sca1HIGHPW1
- cells. Statistical 
significance represents the mean ± s.e.m of at least 3 different experiments. 
*p<0.05 **p<0.01 ***p<0.001  ****p<0.0001. 
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Figure 13. Inhibition of AcvR2B pathway in vivo alters muscle tissue and 
stem cell niche homeostasis. (A) Strategy: 5 week-old male wild-type mice 
were intraperitoneally injected with RAP-031 or vehicle (CTL) every 3 days and 
sacrificed 2 weeks after the first injection. (B) Cross-sections of TA from CTL, 
Mst-/- and RAP-031 mice stained with hematoxylin and eosin. Scale bar, 50µm. 
(C) Fiber size distribution in CTL (gray), Mst-/- (red) and RAP-031 (blue) TA. 
RAP-031 and Mst-/- muscles exhibit fiber hypertrophy. (D- F) Quantification of 
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the number of interstitial (D) and sublaminal (E) nuclei per 100 fibers, and 
nuclei distribution (F) in TAs from CTL, Mst-/- and RAP-031 mice. RAP-031 
treatment resulted in an increase in the number of nuclei, but no change in their 
overall distribution. Values represent the mean number of nuclei ± s.e.m. per 
100 fibers. (G- H)  Quantification of PICs (green) and Satellite cells (red) (G) 
and their ratio (H) for CTL, Mst-/- and RAP-031 TAs. PICs were determined as 
interstitial PW1+Pax7- cells, satellite cells as Pax7+ cells underneath the basal 
lamina. Circle area is relative to the total number of PICs and satellite cells per 
100 fibers. In Mst-/- and RAP-031 the number of PICs and satellite cells was 
significantly increased and the ratio was altered in favor of PICS. (I) Histograms 
showing the number of Ki67+ and Ki67- satellite cells and PICs per 100 fibers in 
CTL and RAP-031 TAs. PICs were determined as interstitial PW1+M-Cadherin- 
cells, satellite cells as M-Cadherin+ cells underneath the basal lamina. For G-I, 
values represent the mean number of positive cells ± s.e.m. per 100 fibers.  
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Figure 14. PICs increase in number but do not directly participate in fiber 
hypertrophy following AcvR2B pathway inhibition in satellite cell-depleted 
muscles. (A) Strategy: the right TA of 10 week-old Pax7DTR/+ males was 
injected with diphteria toxin (DT) to deplete satellite cells while the contralateral 
muscle was injected with PBS 2 weeks before RAP-031 treatment. Mice were 
intraperitoneally injected with RAP-031 or vehicle (CTL) every 3 days and 
sacrificed 8 days after the first injection. (B) Cross-sections of TA muscles from 
CTL (upper panel) or RAP-031 (lower panel) mice injected with PBS (left 
panel) or DT (right panel) stained with hematoxylin and eosin. Scale bar, 60µm. 
(C) Fiber size distribution in CTL (gray) and RAP-031 (blue) TAs injected with 
DT. RAP-031 treatment resulted in muscle hypertrophy even in the absence of 
satellite cells. Values represent the mean number ± s.e.m. per 100 fibers for each 
size. (D) Quantification of the number of sublaminal nuclei per 100 fibers in TA 
from CTL and RAP-031 mice injected with PBS or DT. RAP-031 treatment did 
not result in myonuclei addition when satellite cells are depleted. (E) 
Quantification of satellite cells per 100 fibers in TA from CTL and RAP-031 
mice injected with PBS or DT. Satellite cells were determined as M-Cadherin+ 
cells underneath the basal lamina. The number of satellite cells was markedly 
decreased after DT injection in both CTL and RAP-031 treated mice. (F) 
Number of PICs per 100 fibers in TAs from CTL and RAP-031 mice injected 
with PBS or DT revealed that PICs number was still increased after RAP-031 
treatment in a satellite cell-depleted environment. PICs were determined as 
interstitial PW1+M-cadherin- cells. In D-F, values represent the mean number of 
positive cells ± s.e.m. per 100 fibers. For all graphs, statistical significance was 
calculated from at least 3 animals of each condition. *p<0.05 **p<0.01 
***p<0.001. 
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Figure 15. Inhibition 
of AcvR2B pathway 
improves fiber 
regeneration and 
ameliorates tissue 
homeostasis of 
injured SAT-
depleted muscles. 
(A) Experimental 
design: 6 week-old 
Pax7DTR/+: 
Pax7CreERT2: 
Rosa26mTomatoSTOPmGFP 
mice were injected 
with tamoxifen to 
label satellite cells. 4 
weeks later, the right 
TA was injected with 
DT to ablate satellite 
cells. The 
contralateral muscle 
was injected with 
PBS. After 2 weeks, 
mice were injected 
with either RAP-031 
or vehicle (CTL) 
twice a week for 2 
weeks. The day 
before the last 
injection of RAP-031 
or vehicle both TAs 
were injured by 
cardiotoxin injection. 
Mice were sacrificed 
2 weeks after injury. 
(B) Cross-sections of 
TA muscle from CTL 
(upper panels) and 
RAP-031 (lower panels) mice treated as described in (A) stained with 
hematoxylin and eosin (left panels), Oil-Red O (middle panels) and Sirius Red 
(right panels). Regeneration is more efficient in DT RAP-031 mice as compared 
to DT CTL mice, with a marked reduction in fat and fibrotic tissue deposition 
Scale bar, 50µm. (C) Quantitative analysis of regenerative capacity of TA 
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muscles from mice treated as described in (A). The number of centrally 
nucleated fibers per field in TAs from CTL mice injected with PBS was 
considered as the baseline (zero) and values represent the fold change ± s.e.m. 
normalized accordingly. Muscle fiber regeneration is significantly rescued in DT 
RAP-031 mice as compared to DT CTL mice. *p<0.05 **p<0.01 ***p<0.001. 
 
 
Figure 16. Inhibition of AcvR2B pathway in injured satellite cell-depleted 
muscles promotes activation of the few spared satellite cells to a threshold 
level allowing for muscle regeneration. (A) Representative images of cross-
sections from injured TA muscles of CTL (upper panels) and RAP-031 (lower 
panels) mice injected with DT or PBS as described in fig. 15A, immunostained 
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for mGFP (green) to identify satellite cell-derived fibers and Pax7 (orange) to 
identify satellite cells. mTomato fluorescence is shown in red, dapi staining 
identifies nuclei. The majority of regenerating fibers are satellite cell-derived 
(green) regardless of treatment. White arrowheads: satellite cells. Scale bars, 
30µm. (B-C) Quantification of the number of mGFP+ (B) and mGFP-mTomato+ 
(C) fibers per 100 centrally nucleated fibers for CTL and RAP-031 mice treated 
as described in fig. 15A. Values represent the mean number of positive fibers ± 
s.e.m. per 100 centrally nucleated fibers. (D) Number of satellite cells per field 
indicated no significant increase in RAP-031 DT mice as compared to CTL DT 
mice. Satellite cells were determined as Pax7+ cells. Values represent the mean 
number of positive cells ± s.e.m. per field. *p<0.05 **p<0.01 ***p<0.001. 
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3. Analysis of the EOM stem cell niche 
 
3.1. EOM stem cell niche is conserved throughout aging 
 
The EOMs is a group of skeletal muscles that are required for 
movement of the eyes. As outlined in chapter 3 of Introduction, 
these muscles are particularly resistant to the degenerative 
pathologies that are seen in limb muscles in dystrophic boys and 
mice (Porter, 2002; Porter et al., 1995). We therefore analysed the 
EOM progenitor cell niche and compared our results with those 
obtained previously for limb muscles during both postnatal and 
adult stages. In limb muscle, we had reported previously that both 
PICs and satellite cells undergo a progressive decline after birth 
(Fig. 4 and Mitchell et al., 2010), however these two cell types 
maintain a 1:1 ratio in homeostatic conditions (Fig. 13H and 
Mitchell et al., 2010). We therefore compared 7 week-old wild 
type EOMs and TA muscles and found a 2-fold higher number of 
PICs in EOMs as compared to TA, whereas the number of satellite 
cells was unchanged between the two sets of muscles (Fig. 17A,B) 
leading to a PICs/satellite cells ratio of 2:1 in EOMs as compared 
to 1:1 found in the TA (Fig. 17C). Given the observation that PICs 
secrete promyogenic factors, we suggest that the increased number 
of PICs may account for the maintenance of EOMs under 
myopathic conditions including aging. We next compared 7 week-
old and 18 month-old wild type EOMs and TA. While both muscle 
groups show a decrease in PICs and satellite cell number with age, 
we noted that the PICs/satellite cells ratio remained unchanged in 
old EOMs as compared to young EOMs (Fig. 17C). Specifically, 
PICs from limb muscles undergo a marked decline as compared to 
satellite cells, as old TA exhibits a 0.3:1 ratio between PICs and 
satellite cells (Fig. 17C), suggesting that factors regulating 
progenitor cells within the niche are different in these muscles. We 
further noted a rare population of PW1+ interstitial cells that co-
expressed Pax7 in 7 week-old EOMs, completely or partially 
surrounded by the basal lamina (Fig. 17D,E), raising the 
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possibility that a subset of PICs that are committed to the 
myogenic lineage is present in EOMs. In contrast, PW1+Pax7+ 
interstitial cells were absent in age-matched TA (Fig. 17E). These 
data indicate that the EOM stem cell niche composition is different 
from that seen in limb muscles. However, we failed to detect 
expression of proliferation markers (as Ki67 or PH3) as well as 
myogenic activation marker MyoD in PICs or satellite cells from 
EOMs (data not shown), consistent with observations in TA and 
other skeletal muscles (Fig. 13I and Pallafacchina et al., 2010) in 
contrast with previous reports (McLoon et al., 2004; McLoon and 
Wirtschafter, 2002a). 
 
3.2.  Mdx mice display an unaltered EOM stem cell niche 
 
Mdx skeletal muscles undergo continuous cycles of 
degeneration and regeneration due to a defect in the dystrophin 
gene making it a valuable model for the study of Duchenne 
muscular dystrophy (Burghes et al., 1987; Partridge, 2013; 
Tabebordbar et al., 2013). While the mice and humans vary in the 
degree of disease severity, both share the feature that the EOMs are 
not affected (Porter et al., 1995; Porter et al., 2003). We analyzed 
the EOM and TA stem cell niche in 7 week-old wild-type and mdx 
mice. EOM cross-sections from mdx mice did not display 
histological signs of ongoing regeneration and looked as their wild-
type counterparts, whereas TA cross-sections showed widespread 
regions with centrally nucleated fibers, as also previously reported 
(Wallace and McNally, 2009) (Fig. 18A,B). We observed only one 
restricted region containing some centrally nucleated fibers in 1 out 
of 3 EOMs examined. We also observed an increase in the number 
of interstitial cells in mdx TA as compared to wild type TA, but no 
change in EOMs (Fig. 18C), confirming that mdx EOMs were 
unperturbed. Both satellite cells and PICs were increased in mdx 
TA as compared to its wild-type counterpart (Fig. 18D,E), whereas 
mdx EOMs displayed an unchanged content of PICs and satellite 
cells as compared to wild-type (Fig. 18D,E). Moreover, no 
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increase in sublaminal nuclei content was observed in mdx EOMs 
as compared to their wild-type counterpart (Fig. 18F), 
demonstrating no addition of progenitor cells to myofibers in mdx 
mice (but see McLoon et al., 2007; McLoon and Wirtschafter, 
2002a; Porter, 2002). Taken together, these data support the 
hypothesis that EOM stem cell niche is unperturbed in mdx as 
compared to wild-type. Interestingly, the number of PICs is 
comparable in mdx TA and wild-type EOMs (Fig. 18E). During 
muscle regeneration, FAPs secrete pro-myogenic factors for 
satellite cells (Joe et al., 2010). We demonstrated that PICs include 
the FAPs (Fig. 9) and they secrete FST and IGF-1 (Fig. 12). Taken 
together, these data also suggest that the high number of PICs 
present in EOMs can be a major cause of their sparing in 
degenerative diseases through an increased amount of 
promyogenic and hypertrophic factors which can protect both the 
fibers and the satellite cells, preventing the loss of regenerative 
capacity observed in late stages of muscular dystrophies. 
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Figure 17. Wild-type EOM stem cell niche is intrinsically different from 
limb muscles. (A) Cross-sections of 7-week old EOMs (upper panels) and TA 
(lower panels) from C57Bl6 mice stained for PW1 (green) and the satellite cell 
marker Pax7 (red). Laminin staining (orange) shows the basal lamina. Nuclei 
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were counterstained by DAPI (blue). Arrows indicate PICs, arrowheads indicate 
satellite cells. (B) Number of PICs and satellite cells per 100 fibers in 7-week 
old EOMs and TA cross-sections as stained in (A) revealed a bigger amount of 
PICs but not satellite cells in EOMs compared to TA. (C) Ratio between PICs 
and Satellite Cells per 100 fibers in 7-week old and 18-month old TA and EOMs 
cross-sections demonstrated that EOM but not TA stem cell niche is retained 
throughout aging. PICs were determined as interstitial PW1+Pax7- cells, satellite 
cells were determined as Pax7+ cells underneath the basal lamina. (D) Cross-
section of 7-week old EOMs as stained in (A) also revealed the presence of 
Pax7+ cells totally or partially surrounded by basal lamina and often co-
expressing PW1. Arrows indicate double-labelled Pax7+PW1+ interstitial cells. 
(E) Number of Pax7+ interstitial cells per 100 fibers in 7 w-old EOMs and TA 
cross-sections as stained in (A). For all graphs, values represent the mean 
number of cells ± s.e.m. Statistical significance was calculated from at least 3 
animals of each condition. *p<0.05 **p<0.01 ***p<0.001. 
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Figure 18. 
EOMs from mdx 
and wild-type 
mice exhibit a 
similar muscle 
stem cell niche. 
(A) Cross-
sections of 7-
week old TA 
(upper panels) 
and EOMs (lower 
panels) from mdx 
and age-matched 
wild-type mice 
stained with 
hematoxylin and 
eosin showed 
large 
regenerating 
areas in TA but 
not EOMs from 
mdx mice. (B-C) 
Number of 
centrally 
nucleated fibers 
(B) and 
interstitial nuclei 
(C) per 100 fibers 
indicated the 
presence of an 
ongoing 
regeneration 
process in mdx 
TA but not 
EOMs. (D-E) 
Number of satellite cells per 100 sublaminal nuclei (D) and PICs per 100 
interstitial nuclei (E) revealed an activation of both progenitor cell types in TA 
but not EOMs from mdx mice, as compared to their wild-type counterparts. (F) 
Number of sublaminal nuclei per 100 fibers indicated no myonuclei addition in 
mdx EOMs as compared to wild-type. For all graphs, values represent the mean 
number ± s.e.m. Statistical significance was calculated from at least 3 animals of 
each condition. *p<0.05 **p<0.01 ***p<0.001. 
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DISCUSSION 
 
We described previously a non-satellite cell progenitor 
population in the interstitium of postnatal muscle referred to as 
PW1-expressing interstitial cells (PICs) (Mitchell et al., 2010). 
Although both satellite cells and PICs express PW1/Peg3, satellite 
cells are strongly committed to the skeletal muscle lineage whereas 
a single PIC can generate both smooth and skeletal muscle in vitro 
(Mitchell et al., 2010). Genetic lineage-tracing studies 
demonstrated that PICs and satellite cells do not share a common 
progenitor despite their shared skeletal muscle potential (Mitchell 
et al., 2010). The different lineage origins of PICs and satellite 
cells are further underscored by results obtained here in which we 
show that PICs and satellite cells have distinct transcriptome 
signatures in both juvenile and adult stages. Even though our 
Affymetrix-based screen used juvenile (10 day old) satellite cells, 
we found that genes that have been ascribed to adult and therefore 
fully quiescent satellite cells are already clearly detected at high 
levels including Pax7, FGFR4, and c-met, however we also 
detected the expression of Myf5 and Ki67 consistent with a more 
activated state. During postnatal growth, PICs express many genes 
that play key roles during angiogenesis including the pericyte 
marker NG2 (Dellavalle et al., 2007). Pericytes also possess 
myogenic potential and are proposed to be the muscle resident 
postnatal equivalent of mesoangioblasts (Dellavalle et al., 2007; 
Sampaolesi et al., 2003). Similar to PICs, mesoangioblasts 
contribute to new myofibers following engraftment into damaged 
muscle (Sampaolesi et al., 2006; Sampaolesi et al., 2003) and show 
a mesenchymal and vascular-like profile (Brunelli et al., 2004). We 
note that mesoangioblasts express high levels of PW1 as well as 
PDGFRα (Pessina et al., 2012) suggesting a close relationship 
between these two skeletal muscle resident stem cells. Whereas 
embryonic mesoangioblasts derived from E10.5 dorsal aorta 
express Pax3 and require Pax3 for myogenic and adipogenic 
differentiation (Messina et al., 2009), we note that PICs are not 
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derived from a Pax3 expressing progenitor, however they initiate 
Pax3 and Pax7 expression upon myogenic differentiation (Mitchell 
et al., 2010). The precise relationship between PICs and 
mesoangioblasts remains to be fully elucidated.  
In addition to non-satellite cell progenitors with myogenic 
potential, two recent reports have identified interstitial cells with 
adipogenic potential (Joe et al., 2010; Uezumi et al., 2010). It has 
been subsequently proposed that these two populations may be 
partially or completely overlapping (Natarajan et al., 2010). These 
cells, referred to here collectively as IAPs, are characterized by 
PDGFRα and high Sca1 expression (Joe et al., 2010; Uezumi et 
al., 2010). While these cells do not contribute directly to the 
generation of new myofibers in response to injury, they exert a 
pro-myogenic effect on satellite cells in vitro through paracrine 
interactions although the nature of the signals had not been 
elucidated (Joe et al., 2010). IAPs are also proposed to be the 
source of ectopic fat deposition in diseased muscle due to their 
ability to form fat in vitro and upon grafting either into diseased 
muscle or into pro-adipogenic sites in vivo (Joe et al., 2010; 
Uezumi et al., 2010). More recently, a study has described that 
white adipose tissue present in skeletal muscle contains a 
population of highly inducible brown fat (‘beige’) progenitors that 
express Sca1 and PDGFRα (Schulz et al., 2011). Since IAPs and 
PICs express high levels of Sca1 and PDGFRα in the adult, we 
wondered whether PICs and IAPs constituted a partially 
overlapping population of progenitors. This hypothesis seemed 
likely given our observation that PW1/Peg3 expression is found in 
all adult stem/progenitor cells examined to date including blood, 
brain, bone, skin and gut (Besson et al., 2011). If PW1/Peg3 serves 
as a pan-stem cell marker in adult tissues, we expect PW1/Peg3 
expression to identify all progenitor cells types in a specific tissue 
containing a mixture of cell lineages such as skeletal muscle. In 
this study, we used the PW1nlacZ reporter mouse line (Besson et al., 
2011) to purify PW1/Peg3 expressing cells from skeletal muscle 
during postnatal development and in the adult in order to determine 
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their cell fate potentials and specifically address the relationship of 
the various resident progenitor cells described to date. Our results 
demonstrate that IAPs constitute a sub-population of PICs that can 
be separated based upon PDGFRα expression. Specifically, 
PDGFRα+ PICs are adipogenic progenitors whereas PDGFRα- 
PICs display myogenic potential. Sca1+CD34+PDGFRα+ 
adipogenic progenitors have been shown to be present in 
abdominal murine white adipose tissue that are able to differentiate 
into both brown and white fat (Lee et al., 2012). Adipocyte 
progenitor cells isolated from skeletal muscle are highly committed 
to become brown fat, but can also give rise to white or ‘beige’ fat 
in vitro (Cannon and Nedergaard, 2012; Joe et al., 2010; Kajimura 
et al., 2008; Schulz et al., 2011; Seale et al., 2008; Seale et al., 
2007) or in vivo (Joe et al., 2010). In this study, we report that 
PDGFRα+ PICs express brown fat specific markers (Ucp1 and 
Prdm16) as well as markers for white/‘beige’ fat (i.e. Hoxc9) 
(Walden et al., 2012; Wu et al., 2012), suggesting that PDGFRα+ 
PICs can generate ‘beige’ fat cells or a mixture of brown and 
white/‘beige’ adipocytes. We conclude that PW1/Peg3 expression 
identifies at least three progenitor populations in adult muscle: 
PW1+Pax7+ (satellite cells), PW1+PDGFRα+ (adipogenic 
progenitors), and myogenic interstitial cells that do not express 
Pax7 nor PDGFRα. Markers that are unique to the myogenic 
fraction of PICs remain to be elucidated and a search for such 
markers is presently underway. When cultured in adipogenic 
conditions, the myogenic PDGFRα- PICs express genes consistent 
with adipogenic activation although they fail to generate 
adipocytes. This raises the possibility that these cells possess the 
capacity to enter the adipogenic program but require additional 
signals. Sca1 is a marker widely used to enrich stem cells (Asakura 
et al., 2002; Benchaouir et al., 2004; Gumley et al., 1995; Tamaki 
et al., 2002), and is implicated in lineage commitment and stem 
cell self-renewal (Bonyadi et al., 2003; Ito et al., 2003). While all 
interstitial cells with myogenic or adipogenic potential express 
Sca1 and PW1/Peg3, we note that Sca1+ cells that do not express 
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PW1/Peg3 are limited to a fibroblast-like phenotype in the 
conditions used in this study. In addition, it is noteworthy that Sca1 
is restricted to few species and is not expressed in humans, 
consequently, our findings regarding PW1/Peg3 as a marker of 
stem cells may have additional impact as we have confirmed its 
expression in humans, pig and dog (Messina, manuscript in 
preparation).  
Our analyses of early postnatal skeletal muscle progenitors 
revealed a transient population of PICs that expresses intermediate 
levels of Sca1 (Sca1MED), which disappears between 3 and 5 weeks 
of age. A number of studies have suggested that addition of nuclei 
to myofibers is a primary mechanism of muscle growth up to 3 
weeks of age whereas myofiber volume expansion underlies 
muscle growth at later stages (White et al., 2010). This switch in 
the cellular program underlying postnatal muscle growth is also 
concomitant with a change in the genetic requirement for Pax7 and 
Pax3. Specifically, loss of Pax7 and/or Pax3 prior to 3 weeks of 
age leads to stunted postnatal growth and poor regeneration 
whereas loss of Pax7/3 after 3 weeks of age has little effect 
(Lepper et al., 2009). Taken together, we propose that the transient 
juvenile population of PICs plays a role during early postnatal 
muscle growth, either through fusion with myofibers or by 
providing cues for myogenic progenitors. Interestingly, microarray 
analysis revealed specific expression of the GH receptor in 
Sca1MED juvenile PICs, suggesting a possible stimulation of the 
GH/IGF-1 axis in this cell type during postnatal muscle growth. 
Whether Sca1MED juvenile PICs fuse with myofibers or 
progressively up-regulate Sca1 expression by 3 weeks remains to 
be investigated.  
In addition to a difference in levels of Sca1 expression, we 
note that adult PICs and juvenile Sca1MED and Sca1HIGH PICs 
express PDGFRα while only adult and juvenile Sca1HIGH PICs 
express Tie2 suggesting that the Sca1HIGH PICs in the juvenile and 
adult are the same cell population. In addition, we note that the 
Sca1MED PDGFRα+ juvenile population shows weak adipogenic 
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capacity when grown alone as compared to the unsorted population 
whereas the PDGFRα- population is the only fraction with 
myogenic potential. This suggests that the crosstalk between 
myogenic and adipogenic progenitors described in adult muscle by 
others (Joe et al., 2010; Uezumi et al., 2010) is present in juvenile 
in the PICs population.  
Our data raise a more fundamental issue with regard to 
postnatal and adult stem cells. Satellite cells are quiescent and 
reside in a discreet anatomical location under the myofiber basal 
lamina whereas PICs reside in an interstitial location. Nonetheless, 
these cells are all progenitors that communicate with each other to 
support tissue integrity and regenerative responses (Pannerec et al., 
2012). The observation that all these progenitors express 
PW1/Peg3 suggests a common regulatory program. A recent report 
has shown that PW1/Peg3 is one member of a group of 10 
parentally imprinted genes that are expressed in several somatic 
stem cell lineages in both mice and humans (Berg et al., 2011; 
Pannerec et al., 2012). We note that PW1/Peg3 participates in both 
intrinsic (p53) and extrinsic (inflammatory cytokine signaling) cell 
stress responses (Relaix et al., 2000; Relaix et al., 1998; 
Schwarzkopf et al., 2006), which may reflect a shared response 
mechanism to cell stress in stem cells. Future work will determine 
whether this common cell stress response mechanism in stem cells 
plays a role in pathological outcomes such as ectopic fat deposition 
and fibrosis that are commonly associated with late stage muscle 
diseases.  
Ectopic fat and fibrosis constitute two features of 
degenerative diseases and are well described in muscular 
dystrophies (Glass, 2010; Serrano et al., 2011). Dystrophic muscle 
undergoes continuous cycles of degeneration and regeneration 
leading to chronic inflammation and an eventual depletion or 
exhaustion of the satellite cell pool (Tabebordbar et al., 2013). In 
addition, muscle fibers upregulate catabolic and autophagic 
pathways leading to a reduction of muscle mass and strength 
followed by their replacement with fibrosis and fat (Bonaldo and 
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Sandri, 2013). Coupled with these responses, satellite cells lose 
their regenerative capacity resulting in regenerative failure and the 
eventual loss of muscle tissue (Hikida, 2011; Jang et al., 2011). 
Several studies have reported that activation of the TGFβ/AcvR2B 
pathway stimulates fibrosis and that blocking this pathway in vivo 
can ameliorate the course of several muscle disorders, such as 
Duchenne muscular dystrophy (Bogdanovich et al., 2002; George 
Carlson et al., 2011; Pistilli et al., 2011), amyotrophic lateral 
sclerosis (Morrison et al., 2009), cancer-induced cachexia (Zhou et 
al., 2010a) and sarcopenia (Chiu et al., 2013). A promyogenic role 
has been proposed for interstitial progenitors (Joe et al., 2010; 
Murphy et al., 2011; Uezumi et al., 2010), however an abnormal or 
sustained activation of TGFβ pathway has been proposed to induce 
their overproliferation and deposition of fibrotic extracellular 
matrix (Uezumi et al., 2011).  
PICs are highly responsive to perturbations to the muscle 
microenvironment including injury, age and changes in the 
expression of cell stress effectors including DNA damage repair 
mechanisms (Coletti et al., 2002; Didier et al., 2012; Nicolas et al., 
2005; Schwarzkopf et al., 2006). In addition, Pax7 mutant muscle 
exhibits a massive increase in PICs at birth prior to the loss of 
satellite cells suggesting an interaction between these cell 
populations (Mitchell et al., 2010). Moreover, PICs are present at 
high numbers during the marked increase of muscle mass that 
accompanies postnatal development (Mitchell et al., 2010). We 
report here that inhibition of the AcvR2B pathway leads to a 
marked increase in PICs. In addition, we show that PICs secrete 
FST and IGF-1 that act to block MST-mediated muscle atrophy 
(Amthor et al., 2004; Bodine et al., 2001; Lee et al., 2010; Rommel 
et al., 2001; Trendelenburg et al., 2009). The observation that 
satellite cells express MST and that PICs overcome the MST-
mediated inhibition of satellite cell proliferation through secretion 
of FST and IGF-1 leads to a model in which satellite cell-mediated 
autocrine inhibition is neutralized by neighboring PICs. Given the 
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intimate anatomical relationship between PICs and satellite cells, 
we propose that PICs act primarily as niche support cells in vivo.  
Satellite cell depletion provides an experimental platform for 
pathological conditions in which the satellite cell pool is reduced 
leading to ectopic fat and fibrosis following muscle injury 
(Sambasivan et al., 2011b). Inhibition of the AcvR2B pathway 
results in an increase in satellite cells and PICs in normal muscle, 
however we did not observe a significant rescue of the satellite cell 
population in satellite cell depleted muscle even though the PICs 
undergo a marked expansion. Nonetheless, we observe that 
regeneration is substantially rescued in RAP-031 treated satellite 
cell depleted muscle following injury suggesting that additional 
molecular signals, likely including cell stress mediated responses, 
are required. Our data confirm the requirement of satellite cells for 
regeneration (Lepper et al., 2011; Murphy et al., 2011; Sambasivan 
et al., 2011b) even though other non-satellite cells including PICs 
and pericytes have been identified with myogenic potential 
(Cappellari and Cossu, 2013; Pannerec et al., 2012). While lineage 
analyses reveal the majority of muscle fibers generated in the 
satellite cell depleted muscles come from a residual satellite cell 
population following inhibition of the AcvR2B pathway, we 
cannot exclude that PICs or other resident progenitor populations 
participate in muscle regeneration when the satellite cell 
compartment is intact. We note that a significant number of muscle 
fibers do not express the satellite cell lineage marker following 
regeneration in intact muscle (mGFP-mTomato+ labeled fibers) and 
that this number is increased following AcvR2B inhibition. 
Whether this is due to incomplete Pax7-mediated Cre activity or 
due to the participation of non-satellite cells will require the 
generation of additional lineage-specific markers for the myogenic 
PIC population.  
While the inhibition of the AcvR2B pathway can restore 
muscle regeneration in satellite cell-depleted mice, we did not 
observe a significant rescue of the satellite cell pool suggesting that 
additional signals are required for satellite cell self-renewal. 
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Nonetheless, data provided in this study reveal that targeting the 
muscle stem cell niche should be considered in the design of 
therapeutic strategies aimed at restoring the regenerative potential 
of skeletal muscle in chronic muscle diseases. 
Our data strongly support the hypothesis that interactions 
among muscle progenitor cells are important in regulating muscle 
homeostasis and regeneration and that alterations within the stem 
cell niche account for several muscle diseases. Nonetheless, some 
muscles, such as the EOMs, are resistant to several dystrophies as 
compared to other sets of skeletal muscles of the body (Porter, 
2002; Porter et al., 1995), suggesting that muscle-type specific 
endogenous mechanisms operate in the stem cell niche leading to a 
more efficient regenerative response. We found that EOMs express 
a bigger number of PICs than satellite cells throughout postnatal 
life, in contrast to limb muscles where PICs and satellite cells are 
in equal amounts (1:1 ratio) during postnatal growth and 
adulthood. Nonetheless, old limb muscles exhibit an altered ratio 
between PICs and satellite cells, with a major loss within the PIC 
compartment rather than the satellite cell population, whereas the 
ratio between PICs and satellite cells is conserved in aged EOMs, 
although both cell types undergo a decline in number. As PICs 
secrete promyogenic factors, we suggest that EOM environment is 
more protected than limb muscle from damage or stress. Indeed, 
EOM stem cell niche from mdx mice do not display any particular 
difference as compared to wild type mice and mdx EOMs are not 
affected by the disease. It is interesting to note that the 
regeneration process undergoing in mdx limb muscles induces an 
increase of satellite cells and PICs up to a level comparable to the 
one observed in wild type EOMs. This suggests that mechanisms 
normally occurring during muscle regeneration to promote 
progenitor cell survival, activation and differentiation, are intrinsic 
to the EOM stem cell niche. Further studies of the EOMs promise 
to uncover the molecular cues ultimately leading to specific 
therapeutic approaches for congenital myopathies as well as 
muscle wasting.  
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MATERIALS AND METHODS 
 
Mice. Animal models used were: C57Bl6J PW1IRESnLacZ transgenic 
reporter mice (PW1nlacZ), in which a nuclear operon lactose gene is 
expressed under the control of the Pw1 locus (Besson et al., 2011); 
C57Bl6J mice (Elevage Janvier); GDF-8/myostatin-null mice (Mst-
/-) (McPherron et al., 1997); knock-in heterozygous Pax7DTR/+ 
mice, in which the diphteria toxin receptor (DTR) is expressed 
under the control of the Pax7 promoter (Sambasivan et al., 2011b); 
Tg:Pax7CreERT2 mice, carrying a BAC where a tamoxifen-
inducible Cre recombinase/estrogen receptor fusion protein, 
CreERT2 (Metzger and Chambon, 2001), is expressed under the 
control of Pax7 (Mourikis et al., 2012); Rosa26mTomatoSTOPmGFP 
mice (Jackson Laboratories). Pax7DTR/+ mice were crossed with 
Tg:Pax7CreERT2 and Rosa26mTomatoSTOPmGFP to obtain 
Pax7DTR/+:Pax7CreERT2:Rosa26mTomatoSTOPmGFP animals. All work 
with mice was carried out in adherence to French government 
guidelines. 
 
RAP-031 treatment. 5-weeks old C57Bl6 males, and 10-weeks 
old Pax7DTR/+ or Pax7DTR/+Pax7CreERT2Rosa26mTomatoSTOPmGFP 
mice were injected intraperitoneally with RAP-031 or vehicle 
(TBS) 10mg per kg-1. Mice were weighed and dosed twice a week 
for 2 weeks and the day of sacrifice.  
 
Tamoxifen treatment. 6 weeks-old Pax7DTR/+:Pax7CreERT2: 
Rosa26mTomatoSTOPmGFP mice were injected intraperitoneally every 
day for 4 days with tamoxifen (250–300µl, 20 mg/ml; Sigma 
Aldrich) diluted in sunflower seed oil/5% ethanol. 
 
Toxins injections. Mice were anaesthetized by intra-peritoneal 
injection of ketamine (100mg.kg-1) and xylazine (10mg.kg-1) in 
sterile saline solution. A total volume of 15-30µl was used for one 
single intramuscular injection of diphtheria toxin (DT) from 
Corynebacterium diphtheria (Sigma Aldrich) at 1ng.g-1 of body 
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weight or PBS into the TA muscle using 30G Hamilton syringe. 
Muscle injury was induced by intramuscular injection of 40µl of 
cardiotoxin from Naja mossambica (Latoxan) at a concentration of 
10µM. 
 
FACS analysis. For fluorescence-activated cell sorting, limb 
muscles from 1-7 week old PW1nlacZ or C57Bl6J mice were minced 
and digested in HBSS (Hank’s Balanced Salt Solution, GIBCO) 
containing 2 μg.ml-1 collagenase A (Roche), 2.4 U.ml-1 dispase I 
(Roche), 10 ng.ml-1 DNAse I (Roche), 0.4 mM CaCl2 and 5 mM 
MgCl2 as described previously (Besson et al., 2011; Mitchell et al., 
2010). Primary antibodies at a concentration of 10 ng.ml-1 were:  
rat anti-mouse CD45-APC (BD Biosciences), rat anti-mouse 
Ter119-APC (BD Biosciences), rat anti-mouse CD34-E450 
(eBiosciences), rat anti-mouse Sca1-A700 (eBiosciences), and rat 
anti-mouse PDGFRα-PE (CD104a, eBiosciences). Cells were 
incubated for 30 minutes on ice. Cell pellets were washed twice 
before incubation with 5-Dodecanoylaminofluorescein Di-b-D-
Galactopyranoside (C12FDG, 60µM, Life Technologies) 1 hour at 
37°C. Cells were washed once with ice-cold HBSS, filtered and re-
suspended in HBSS containing 0.2% (w/v) BSA, 1% (v/v) 
penicillin-streptomycin and 10 ng.ml-1 DNAse I.  Flow cytometry 
analysis and cell sorting were performed on a FACSAria (Becton 
Dickinson) with appropriate isotype matching controls. Ter119+ 
and CD45+ cells were negatively selected and the remaining cells 
were gated based on their CD34 and Sca1 expression. PDGFRα 
positive or negative cells were sorted in the Sca1HIGHPW1+ and 
Sca1HIGHPW1- fractions as well as the Sca1MED fraction. Purified 
cell populations were cultured as described below. For 
immunocytochemical analyses, freshly sorted cells (4,000 cells per 
well) were immediately centrifuged in 96-well plate (Becton 
Dickinson) coated with 0.1% porcine gelatin (Sigma) and 
subsequently reacted with X-Gal as described previously (Gross 
and Morgan, 1999). For immunofluorescence analyses, freshly 
sorted cells were immediately centrifuged onto 8-well chamber 
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glass slides (10,000 cells per well) (Thermo Scientific) for 5 
minutes at 100g and immunostained for PW1 and Pax7 or 
PDGFRα, as described below. Quantitative analyses were 
performed by counting the number of positive cells out of a 
minimum of 300 cells in randomly chosen fields for each of three 
independent experiments. 
 
Cell culture. Cells from limb muscles of 1-7 week old mice were 
obtained as described above. Immediately after sorting, cells were 
plated on gelatin-coated dishes at a density of 2,000 cells per cm2 
for myogenic differentiation and at a density of 6,000 cells per cm² 
for adipogenic differentiation. Cells were grown for one week in 
high-glucose Dulbecco’s modified eagle medium (DMEM, Gibco) 
supplemented with 2.5 ng.ml-1 bFGF (Invitrogen), 20% heat-
inactivated FBS (Invitrogen), 10% heat-inactivated horse serum 
(Gibco), 1% (v/v) penicillin-streptomycin (Gibco), 1% (v/v) L-
Glutamine (Gibco) and 1% (v/v) Na-pyruvate (Gibco). Medium 
was changed every 2 days. For myogenic differentiation, cells were 
transferred to differentiation medium (DM) for 2 days: DMEM 
containing 5% (v/v) horse serum and 1% (v/v) penicillin-
streptomycin. For adipogenic differentiation, cells were transferred 
to adipogenic differentiation medium (ADM) for 5 days: DMEM 
containing 20% (v/v) FBS, 1% (v/v) penicillin-streptomycin, 0.25 
μM dexamethasone (Sigma), 0.5 mM isobutylmethylxanthine 
(Sigma), 1 μg.ml-1 insulin (Sigma) and 5 μM troglitazone (Sigma). 
Medium was changed every 2 days. 
 
Transwell co-culture experiments: purified satellite cells were 
plated in the lower chamber at a density of 100 cells/cm2. PICs 
were plated on the membrane of the insert well (1µm pore size, BD 
Biosciences) at 3,000 cells per cm2. Cells were grown for 1 day in 
GM before adding the following factors: recombinant myostatin 
(R&D Systems) was added at 0, 20, 200 or 2000 ng.mL-1: human 
follistatin blocking antibody (αFST) (R&D Systems), mouse IGF-
1 blocking antibody (αIGF1) (R&D Systems) and isotype matched 
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IgG (R&D Systems) were used at 4µg.mL-1 (R&D Systems). After 
2 days, cells were fixed with 4% (w/v) paraformaldehyde (Sigma 
Aldrich) and the number of cells per colony was counted. At least 
3 independent experiments were performed for each condition. 
 
Histological analyses. Tibialis anterior (TA), soleus, plantaris and 
gastrocnemius muscles were removed, weighed and snap frozen in 
liquid nitrogen-cooled isopentane (Sigma Aldrich) as previously 
described (Mitchell et al., 2010). In the case of 
Pax7DTR/+:Pax7CreERT2:Rosa26mTomatoSTOPmGFP mice, TA muscles 
were fixed 2 hours in 4% (w/v) paraformaldehyde (Sigma 
Aldrich), incubated overnight in 20% (w/v) sucrose (Sigma 
Aldrich) and frozen in liquid nitrogen-cooled isopentane (Sigma 
Aldrich). Muscles were cryosectioned (7µm) before processing. 
 For immunofluorescence, TA cryosections were fixed in 4% 
(w/v) paraformaldehyde and processed for immunostaining as 
described previously (Mitchell et al., 2010). Primary antibodies 
used were: PW1 (Relaix et al., 1996) (rabbit, 1:3000), Pax7 
(mouse, Developmental Studies Hybridoma Bank, 1:15), MyoD 
(mouse, BD Biosciences, 1:100), alpha-smooth muscle actin 
(rabbit, Sigma, 1:200), SM22-alpha (rabbit, Abcam, 1:200), MF20 
(mouse, Developmental Studies Hybridoma Bank, 1:50), 
PDGFRα-biotin (mouse, R&D systems, 2.5ng.mL-1), M-Cadherin 
(mouse, Nanotools, 1:100), Ki67 (mouse, BD Biosciences, 1:100), 
Ki67 (rabbit, Abcam, 1:100), GFP (chicken, Abcam, 1:500), 
laminin (rabbit, Sigma, 1:100). Antibody binding was revealed 
using species-specific secondary antibodies coupled to Alexa Fluor 
488 (Molecular Probes), Cy3 or Cy5 (Jackson Immunoresearch). 
Nuclei were counterstained with DAPI (Sigma Aldrich).  
To stain nuclei and muscle fibers, cryosections were stained 
with haematoxilin and eosin (H&E) (Sigma Aldrich).  
To stain lipids, cells and cryosections were fixed in 10% 
formalin (Sigma Aldrich) for 5 minutes at 4°C, rinsed in water and 
then 100% propylene glycol (Sigma) for 10 minutes, stained with 
Oil red O (Sigma Aldrich) for 10 minutes at 60°C, placed in 85% 
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propylene glycol for 2 minutes and rinsed in water. Nuclei were 
counterstained with Mayer’s Hematoxylin Solution (Sigma).  
To detect collagen depositions, cryosections were stained 
with Mayer’s haematoxylin (Sigma Aldrich) for 10 minutes, rinsed 
in running tap water for 20 minutes, then stained with 1.3% (w/v) 
Picro-sirius Red solution (Sigma Aldrich) for 45 minutes and 
washed twice in acidified water.  
Fiber size distribution was measured from cryosections 
obtained from the mid-belly of TA stained with laminin, images 
were captured on a Zeiss AxioImagerZ1 microscope, and 
morphometric analysis was performed using MetaMorph7.5 
(Molecular Devices).  
Cells in culture were quantified by counting at least 300 
cells from randomly chosen fields for each of 3 independent 
experiments. Fusion indexes were quantified by counting the 
number of nuclei in MF20+ cells per total number of nuclei (Coletti 
et al., 2002; Mitchell et al., 2010; Schwarzkopf et al., 2006). 
Adipogenic potential was quantified by counting the number of 
nuclei in Oil red-O+ cells per total number of nuclei. Images were 
acquired using a Leica DM-IL inverted fluorescence and light 
microscope, Leica DM fluorescence and light microscope or Leica 
SPE confocal microscope. 
For quantitative analyses of immunostained tissues, 
positive cells were counted in at least 5 randomly chosen fields per 
muscle section of at least 3 animals for each condition. 
 
Micro-array analysis.  For micro-array analysis (GeneChip MOE 
430 2.0, Affymetrix) RNA was extracted from freshly FACS 
sorted PICs and satellite cells from 1-week old C57Bl6 limb 
muscles, using RNeasy microkit (Qiagen) according to 
manufacturer’s recommendations. Three independent samples for 
each experimental group were sent for analysis to PartnerChip 
(Génopole d'Evry, France). Statistical analysis was performed 
using a Fold Change threshold=1 and p-value=0,01. Subsequent 
analyses were performed using the Gene Ontology database. The 
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microarray analysis has been deposited in NCBI’s Gene 
Expression Omnibus and is accessible through GEO Series 
accession number GSE40523 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40523). 
 
RNA extraction and RT-PCR.  RNA extracts were prepared from 
a minimum of 2 × 104 freshly sorted cells using RNeasy Micro Kit 
(Qiagen) according to manufacturer’s instructions, and reverse 
transcribed using the SuperScript First-Strand Synthesis System 
(Life Technologies). Semi-quantitative PCR was performed using 
ReddyMix Master Mix (Thermo Scientific) under the following 
cycling conditions: 94°C for 5 min followed by 30 cycles of 
amplification (94°C for 30 seconds, 60°C for 30 seconds and 72°C 
for 1 min) and a final incubation at 72°C for 10 minutes. Primers 
sequences used are listed in Table 3. 
 
Statistical analysis. All statistics were performed using an 
unpaired Student’s t-test in the StatView software. Values 
represent the mean ± s.e.m. *p<0.05, **p<0.01, ***p<0.001 and 
****p<0.0001. 
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Table 3. Primers used for semi-quantitative PCR. 
Gene Forward primer Reverse primer 
18S CGGCTACCACATCCAAGGAA TATACGCTATTGGAGCTGGAA 
CD68 AGGTCCAGGGAGGTTGTGA CCGCCATGTAGTCCAGGTAG 
FABP4/ 
Ap2 ACCCTCCTGTGCTGCAGCCTT TGTGGCAAAGCCCACTCCCACT 
FGFR4 ATCTTTCAGGGGACACCAGCTTTG TGCCCTCTTTGTACCAGTGACGA 
Hoxc9 GCAGCAAGCACAAAGAGGAGAAG GCGTCTGGTACTTGGTGTAGGG 
Ki67 GCATGTATCACCTGAGCCTGTGAA TGACTTGGCCCCGAGATGTAGATT 
Myf5 AGCTGGCTCTTCAGGAGACA ACGTGATAGATAAGTCTGGAG 
MyoD ACATAGACTTGACAGGCCCCGA AGACCTTCGATGTAGCGGATGG 
Myogenin CTAGAGGCCCTTGCTCAGGTC GAAATGATCTCCTGGGTTGG 
NG2 TCCAGATCACTGGGCCTTACTT CTCTGAGGCATTAGCTAGCAGAAC 
P2Y14 GAAGCCAGACGTGAAGGAGTTCAT GCAAGCTTCGTCAACAGAATCCAG 
Pax3 ACCAGGCATGGATTTTCAAGC GAGGGGAGAGAGCATAGTC 
Pax7 TCTTACTGCCCACCCACCTA AGGAAGAAGTCCCAGCACAG 
PDGFα AGACCAGGACGGTCATTTACGAGA CTTCCTGACATACTCCACTTTGGC 
PDGFRα GACGAGTGTCCTTCGCCAAAGTG CAAAATCCGACCAAGCACGAGG 
PDGFRβ GCAGCGACACTCCAACAAGCA TCACTCTCCCCAGTCAGGTTCAAG 
Prdm16 CAGCACGGTGAAGCCATTC GCGTGCATCCGCTTGTG 
QPRT GAACGGGTGGCTCTTAACAC CAGGCTGCTACATTCCACCT 
SM22 TAATGGCTTTGGGCAGTTTG TGCAGTTGGCTGTCTGTGAA 
Tie2 TGGACTCTTTAGCCGGCTTAGTTC CAGTGGATCTTGGTGCTGGTTCAT 
UCP1 ACTGCCACACCTCCAGTCATT CTTTGCCTCACTCAGGATTGG 
Vimentin AGTCAAACGAGTACCGGAGACA GTATTCACGAAGGTGACGAGCCAT 
Myostatin GGCTCAAACAGCCTGAATCCAA CCAGTCCCATCCAAAGGCTTCAAA 
Follistatin CCCCAACTGCATCCCTTGTAAA TCCAGGTGATGTTGGAACAGTC 
ALK-2/ 
AcvR1 ATGACTACCTTCAGCTCACT CTTCGCCAGAGAAGTTAATG 
ALK-4/ 
AcvR1B ACCGCTACACAGTGACCATT TCTTCACATCTTCCTGCACG 
ALK-5/ 
TGFβR1 ATCCATCACTAGATCGCCCT CGATGGATCAGAAGGTACAAGA 
AcvR2A CTTAAGGCTAATGTGGTCTC GACTAGATTCTTTGGGAGGA 
AcvR2B ATCGTCATCGGAAACCTCCC CAGCCAGTGATCCTTAATC 
TGFβR2 CGTGTGGAGGAAGAACAACA TCTCAAACTGCTCTGAGGTG 
Smad2 CGGAACCTGCATTCTGGTGTTCAA CTCAGCAAACACTTCCCCACCTAT 
Smad3 ATTTTCGTCCAGTCTCCCAACTGC GCCTTTGACGAAGCTCATACGGAT 
Smad4 AGGCAAAGGAGTGCAGTTGGAATG TGACACTGCCGCAGATCAAAGA 
BMP-2 TGCTCAGCATGTTTGGCCTGAA AAACTCGTCACTGGGGACAGAACT 
IGF-1 IEa 
(416 bp) ATTTAAGATCTGCCTCTGTGACTTCTT TCTTGTTTCCTGCACTTCCTCTACT 
IGF-1 IEb 
(468 bp) ATTTAAGATCTGCCTCTGTGACTTCTT TCTTGTTTCCTGCACTTCCTCTACT 
IGF-1R GAGAAAAGGGAATTTCGTCCCAAATAAAAGG CTATGGTGGAGAGGTAACAGAGGTC 
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